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ABSTRACT 
Fluctuations in autonomic cardiovascular regulation during exposure to high altitude may increase the risk of heart at-
tack during waking and sleep. This study compared heart rate variability (HVR) and its components during sleep at low 
altitude and after 30 - 41 hours of acclimatization at high altitude (3480 m) in five mountain marathon runners con-
trolled for diet, drugs, light-dark cycle and jet lag. In comparison to sea level, RR-intervals during sleep at high altitude 
decreased significantly (P < 0.001). The significant increase in sympathetic autonomic cardiovascular modulation at 
high altitude protects against excessive oxygen deprivation during sleep. Increases in R-R intervals can require longer 
periods of acclimatization at 3480 m to mitigate the effects of altitude/hypoxia on sympathetic tone, thus reducing car-
diovascular distress at rest during waking and sleep and probably before during and after athletic performance at alti-
tude. 
 
Keywords: Heart Rate Variability; Very Low Frequency Fluctuation (VLF, <0.04 Hz) Rhythm; Low-Frequency (LF, 
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1. Introduction 
1.1. Heart Rate Variability 
Intrinsic to pacemaker tissues, cardiac automaticity is re- 
gulated by the central nervous systems (CNS). Control of 
the cardiac cycle is also mediated by local and autonomic 
nervous system components: the parasympathetic influ- 
ence on heart rate is modulated by acetylcholine released 
by the vagus nerve on the sinoatrial node and the sympa- 
thetic influence by the release of epinephrine and nore- 
pinephrine. Under resting conditions, vagal modulation 
and tone predominate at the level of the sinoatrial node. 
Vagal and sympathetic activities interact constantly [1 
hereinafter Task Force 1996]. 
In the sympathovagal and thoracic systems, CNS con- 
trol and influences on the autonomic mechanism can be 
physiologically and voluntarily cut off to different de- 
grees during relaxed attentive waking and involuntarily 
during the progressive deepening of slow-wave sleep [1]. 
Alterations in the autonomic nervous system may give 
rise to cardiovascular and/or cerebrovascular diseases 
and have been frequently associated with death in hu- 
mans. Research into predisposition to arrhythmias and 
increased sympathetic activity or reduced vagal activity 
has led to the development of quantitative markers of 
autonomic activity [1]. 
The Task Force [1] has suggested that cardiovascular 
changes can be investigated non-invasively by electro- 
cardiography (ECG) and by common parameters derived 
from ECG such as heart rate variability (HRV), i.e., the 
variation in the duration of two consecutive R-R intervals. 
R-R interval variations during resting condition are pre- 
cisely tuned by reflexes directed to the sinus node and 
modulated by central (vasomotor and respiratory centre) 
and peripheral (arterial pressure and respiratory move- 
ments) oscillators, particularly during high altitude ex- 
posure. Analysis of R-R intervals provides information 
about the state and function of central oscillators, sympa- 
thetic and vagal efferent activities, humoral cardiac fac- 
tors, and sinus node characteristics [1]. *Corresponding author. 
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It has also been reported by the Task Force [1] and by 
Lanfranchi et al. [2] that the risk of cardiac disease can 
be evaluated by means of spectral analysis of the vari- 
ability in the R-R interval in order to determine high- 
frequency ([HF] 0.15 - 0.4 Hz) rhythm, which primarily 
reflects respiratory-driven vagal modulation of sinus rhy- 
thm, and low-frequency ([LF] 0.04 - 0.15 Hz) rhythm, 
which appears to have a widespread neuronal genesis. LF 
is also considered as a marker of sympathetic modulation 
(expressed in normalized units) and/or as a parameter 
that includes both sympathetic and vagal modulation. 
Thermoregulation-related HRV, so-called very low fre- 
quency fluctuation ([VLF] <0.04 Hz) rhythm is also used 
to analyze HRV. However, explanation of the VLF com- 
ponent of HRV is less defined than the LF or the HF 
component. VLF, LF and HF power are usually meas- 
ured in absolute values of power (milliseconds squared 
[ms2]). LF and HF can be also measured in normalized 
units (NU) to emphasize the controlled and balanced be- 
havior of the two branches of the autonomic nervous sys- 
tem, as well as baroreflex responsiveness to beat-to-beat 
variations in arterial blood pressure [1]. Normalization of 
LF and HF power tends to minimize the effect of the 
changes in the total power on the values of these two 
components. Normalized units and absolute values of LF 
and HF power should both be calculated to provide a 
better measurement of the degree of autonomic modula- 
tion rather than just the level of autonomic tone [1]. 
To date, little has been reported about the effect of dif- 
ferent environments (type of nature, physical activity, 
emotional circumstances, environment of the group) on 
HRV analysis [1]. 
1.2. Type of Nature 
1.2.1. Hypobaric-Hypoxic Conditions 
Hypoxia affects ventilator control circuits and autonomic 
cardiovascular regulatory mechanisms in normal subjects 
and in those with cardiac and/or respiratory failure. In 
hypobaric-hypoxic conditions, HRV analysis can be con- 
sidered as an expression of the changes in respiratory 
frequency oscillation and of respiratory sinus arrhythmia 
not mediated by the beta adrenergic block, yet modulated 
by the vagus nerve; furthermore, changes in the cardiac 
vagal nervous system result in proportional changes in 
R-R intervals. During exposure to hypobaric-hypoxic and 
during waking conditions, HRV is reduced, with a rela- 
tive increase in the LF component. In mountaineers, the 
relative increase in the LF component is thought to be 
due to increased sympathetic modulation of the sinus 
node in response to high altitude. Acute exposure to hy- 
pobaric-hypoxic conditions at high altitude increases the 
risk of cardiovascular stroke, heart attack and death [2]. 
1.2.2. Sleep-Wake Cycle 
At low altitudes, HR is normally higher during daytime 
hours and lower at night. During wakefulness, HRV os- 
cillates in relation to physical activity; during the sleep 
cycle it changes with the passage from non-rapid eye 
movement (NREM) to rapid eye movement (REM) sleep 
to awakening periods during sleep (W) episodes [3]. 
Changes in HR may precede changes on the electroen- 
cephalogram (EEG). Shorter R-R intervals are believed 
to reflect sympathetic dominance and are associated with 
waking and REM sleep, while longer R-R intervals re- 
flect vagal dominance probably coincident with sleep 
dampening. This allows for HRV analysis in the LF, HF, 
and LH:HF frequency domains as a tool for exploring 
sympathovagal balance continuously during sleep at alti- 
tude. To our knowledge, HRV during the nocturnal sleep- 
wake cycle at high altitudes in humans has been less in- 
vestigated than at low altitude in humans and animals. 
1.3. Environment and Physical Activity of 
Mountain Marathon Athletes 
Mountain marathoners, also called sky runners, are ath- 
letes who perform marathons and races at high altitude. 
Their anthropometric characteristics are similar to those 
of marathoners competing at sea level. Various physio- 
logical, biochemical, hematological and psychological 
parameters studied in these athletes during waking, be- 
fore, during, and after races have shown that changes in 
these parameters are transient, promptly return to normal, 
and produce no evident clinical symptoms or diseases. 
The endurance performance of mountain marathoners is 
appreciably reduced at high altitude. Based on their an- 
tropometrical characteristics, mountain marathoners may 
be considered a suitable group for studying possible pa- 
thological effects of stay and exercise at altitude [4-13]. 
Unlike the situation described in Lanfranchi and co- 
workers [2], the medical staff involved in this study, dur- 
ing the long-term follow-up of a group of mountain ma- 
rathon athletes during training and athletic competition 
from sea level to 5500 m, has never recorded signs of 
acute mountain sickness (AMS) [4-13]. Regular exercise 
is thought to modify autonomic balance and accelerate 
the safe recovery of physiological sympathovagal inter- 
action [1]. Exercise and training of the mountain mara- 
thon runners might have decreased their risk of cardio- 
vascular mortality and sudden cardiac death at low and 
high altitudes, as well as prevented syncope episodes, 
which can occur after the end of races at high altitude 
[12]. 
1.4. Mountain Environments 
When undertaken in mountain environments, studies on 
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humans typically lack the controlled conditions of the 
laboratory. High-altitude research, as in the present study, 
is limited to a small number of anthropometrically con- 
trolled subjects. Even so, for future high and very high 
altitude expeditions, studies on anthropometrically con- 
trolled subjects transiently and naturally exposed to the 
mountain environment can give, albeit under less rigor- 
ously controlled conditions, important insights into HRV 
that may not completely be gleaned from sea-level labo- 
ratory studies. The data presented here were collected 
during sleep, in sea-level native mountain marathon run- 
ners, at 122 m and at an altitude of 3480 m, in clinostatic 
position so as to avoid, or at least reduce, autonomic me- 
chanisms correlated with the central and peripheral auto- 
nomic nervous systems and effects related to the time of 
eating, jet lag, light-dark cycle and motor activities [14]. 
1.5. Aim of the Study 
Given the direct and indirect physiological effect of hy- 
pobaric-hypoxia on the cardiovascular system [15], fluc- 
tuations in autonomic cardiovascular regulation during 
exposure to high altitude [2], the increased risk of heart 
attack, and the instability of the cardiovascular system 
during sleep, this study analyzed HRV by calculating the 
average of the spectral component of stacked series of 
sequential power spectra from short ECG segments last- 
ing 0.5 minutes [16] during sleep: at sea level and be- 
tween 30 and 41 h of acclimatization at 3480 m altitude 
in a small sample of anthropometrically well character- 
ized mountain marathon runners [4-13]. The analysis of 
HRV during sleep at 3480 m can provide firmer ground 
for studying and diagnosing overtraining at high altitude 
of mountain marathon runners exposed to hypobaric-hy- 
poxic conditions. HRV measurements at high altitude 
may offer useful data for standard physiological evalua- 
tion and for formulating recommendations on increasing 
or reducing acclimatization time to defined hypobaric- 
hypoxic conditions and reduce cardiovascular distress at 
low altitude and during performance at high altitude in 
particular. 
2. Material and Methods 
2.1. Environment of the Group 
Five adult mountain marathon runners, native to sea level, 
with at least 20 years experience of competitive races and 
climbing at altitudes between 122 m and 5500 m, aged 
from 38 to 41 years, clinically and psychologically tested 
before, during and after competitions at high altitude 
(>2500 m) were recruited for this study [4-13]. 
The average body weight for the five subjects was 
65.8 ± 4 kg; the average height was 176 ± 3.7 cm and the 
average aerobic power was 61.4 ± 2.7 ml·kg−1·min−1. The 
use of any drugs, dietary and neuroactive supplements 
was suspended for one week before the start of the study. 
Effects of light-dark and jet-lag interference on acclima- 
tization were excluded by the location of the study. 
2.2. Polysomnographic Recording 
Polysomnographic recording procedures were carried out 
in accordance with Directive 86/609/EEC for experimen- 
tal human care. Informed consent prior to each experi- 
mental session was given by all five subjects and by the 
international medical staff of the Federation of Sport at 
Altitude. The study was conducted during normal sleep 
time (between 10 p.m. and 9 a.m.). Workouts were sus- 
pended on the days the measurements were taken. 
Polysomnographic recordings were taken in dedicated 
dark, isolated, silent rooms at 122 m (Milan, Italy) at a 
barometric pressure (PB) of 742  7.7 mm Hg and after 
an acclimatization period of 30 - 32 or 38 - 41 h after 
reaching 3480 m at a PB of 495.4  3.19 mm Hg. The 
recordings were performed to study the electroencepha- 
logram (EEG), submental electromyogram (EMG), elec- 
trooculogram (EOG), electrocardiogram (ECG) and the 
percent of peripheral arterial oxygen saturation (%SpaO2) 
signals. All signals were amplified and registered at a 
sampling rate of 250 Hz, then analyzed off-line accord- 
ing to standard criteria (Somnological 3, EmblaMedcare, 
Flaga®, Monza, Italy). Electrocardiographic recordings 
were taken with a bipolar derivation from two cardiac 
electrodes placed in V2 in the fourth left intercostal re- 
gion along the sternum, and in V4 in the fifth left inter- 
costal region on the hemiclavear line. 
The polysomnographic tracings containing the ECG 
signals were scored as follows: awakening during sleep 
(W), S1 + S2 and S3 + S4 of slow-wave sleep, also 
called NREM sleep, and REM sleep, according to stan- 
dard criteria developed by Rechtschaffen and Kales [17] 
in 30-second artifact-free epochs [16]. 
Automatic analysis of HRV values was performed us- 
ing Somnological 3 software (Embla), autoregressive 
model, order 12, following the rules of the Task Force [1] 
in a total of stacked series of sequential 30-second arti- 
fact-free epochs of awakening during sleep (W), S1 + S2 
and S3 + S4 of NREM sleep, and of REM sleep. 
This analysis focused on the average of the R-R inter- 
vals, the power of the very low frequency (VLF), low 
frequency (LF) and high frequency (HF), the normalized 
unit of the low Frequency and high frequency (LFRRNU 
and HFRRNU), which were obtained by dividing the 
power of each component by the total variance, from 
which the VLF was subtracted, and by multiplying them 
by 100, and on the total power (TP) [Task Force 1]. 
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2.3. Statistical Analysis 
The results are expressed as the mean  standard devia- 
tion (SD) or standard error mean (SEM). Probabilities 
lower than P < 0.05 were accepted as significant. ANOVA 
and post hoc tests were also performed. Simple linear re- 
gression analysis between the (%SpaO2, PCO2) (personal 
observations) and the ECG parameters was also per- 
formed using the Stat-View program. 
3. Results 
None of the five subjects ever experienced AMS during 
the present study. There were no differences in the time 
of evaluation of the subjects. During sleep the %SpaO2 
and PCO2 at high altitude was significantly lower than 
that recorded at sea level (average SD: %SpaO2 80  
3.64 at 3480 m vs 95.6 ± 0.85 at 122 m; P < 0.05; PCO2: 
28.25 ± 2.33 at 3480 m vs 41.21 ± 3.38 at 122 m). 
3.1. R-R Intervals (ms) 
3.1.1. Sea Level (122 m) 
At 122 m, the averages of the recorded R-R intervals 
were similar between all sleep stages and ranged from 
1223 ms during the awakening period during sleep (W), 
1300 ms during S1+S2 and 1262 ms during S3 + S4 of 
NREM sleep, to 1272 ms during REM sleep (Table 1). 
The averages of the R-R intervals recorded at 122 m 
during the nocturnal sleep-wake cycle suggested a pre- 
valence of vagal tone during all four sleep stages and in 
all five subjects. 
3.1.2. High Altitude (3480 m) 
At 3480 m, the averages of the R-R intervals recorded 
during sleep ranged from 935 ms during W, 1054 ms 
during S1 + S2 and 993 ms during S3 + S4 of NREM 
sleep, to 990 ms during REM sleep. 
The averages of the R-R intervals recorded at altitude 
during the awakening period during sleep (W: 935  88) 
were significantly shorter than those recorded during S1 
+ S2 (1054  73; P < 0.05) (Table 1). The averages of 
the R-R intervals recorded during sleep suggested an 
increase in sympathetic tone during W, S3 + S4 NREM 
sleep and REM sleep, and a persistent significant in- 
crease in vagal tone during the light phases of NREM 
sleep. 
3.1.3. Sea Level (122 m) and High Altitude (3480 m) 
Changes in ECG, with a reduction in the R-R intervals 
(ms) recorded during sleep, became evident between 30 
and 41 h of acclimatization at 3480 m compared to mea- 
surements taken at 122 m during sleep: signs of sinus 
arrhythmia during periodic breathing; during S1 + S2 of 
NREM sleep, and during REM sleep were evident (Ta- 
ble 1). In all five mountain marathon runners, the aver- 
ages of the R-R intervals during W, S1 + S2 and S3 + S4 
of NREM sleep, and REM sleep were significantly shor- 
ter at altitude than those recorded at sea level (P < 0.01 - 
P < 0.001). 
The averages of the R-R intervals during W (935  88), 
S1 + S2 (1054  73) and S3 + S4 (993  55) of NREM 
sleep, and REM sleep (990  68) were significantly 
shorter at altitude than those recorded at sea level [(W: 
1223  102; P < 0.001); (S1 + S2: 1300  69; P < 0.001); 
(S3 + S4: 1262  65; P < 0.001); (REM: 1272  77; P < 
0.001)]. The averages of the R-R intervals suggested a 
prevalence of sympathetic tone during all sleep stages at 
altitude and a prevalence of vagal tone during sleep at 
sea level.  
Simple regression analysis between the average %SpaO2 
during sleep at low and at high altitudes was significantly 
correlated (DF1,9 R-squared 0.477, coefficient 623.58, 
F-test7,31, P = 0.0269, t = 2.704) with the average changes 
in R-R intervals. 
3.2. Total Power of Very Low Frequency [(VLF, 
ms2) (<0.04 Hz)] vs 
Thermoregulation-Related HRV 
3.2.1. Sea Level (122 m) 
At 122 m, the averages of VLF were: 22,455 ms2 during 
W; 10,217 ms2 during S1 + S2; 3977 ms2 during S3 + S4, 
and 17,016 ms2 during REM sleep. The average VLF 
analyzed in 190 30-second epochs during the awakening 
period during sleep (W: 22,455  17,267) was signifi- 
cantly longer than the average VLF analyzed in 226 
30-second signal epochs during S3 + S4 of NREM sleep 
(3977  3531; P < 0.0046) (Table 2). The average VLF 
analyzed in 226 30-second epochs during S3 + S4 of 
NREM sleep (3977  3531) was significantly shorter 
than that analyzed in 175 30-second epochs during REM 
sleep (17,016  13,612; P < 0.009).  
These data collected at 122 m above sea level indicate 
that during the deepening of synchronized sleep the ther- 
moregulation-related component (VLF) of HRV decreased, 
with an increase in vagal tone. The averages of VLF dur- 
ing REM sleep increased, approaching the average re- 
corded during W, thus suggesting a high level of sympa- 
thetic tone during both stages (W and REM). 
3.2.2. High Altitude (3480 m) 
At 3480 m, the averages of VLF were: 17,539 ms2 during 
W; 8452 ms2 during S1 + S2 of NREM sleep; 3179 ms2 
during S3 + S4 of NREM sleep; and 15,765 ms2 during 
REM sleep. 
The average VLF recorded in 271 30-second epochs            
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Table 1. Averages of the R-R intervals (ms) analysed in 5 altitude marathon runners, recorded in 30-second physiologically 
defined number of signal epochs according to the standard criteria developed by Rechtschaffen and Kales (1968) during the 
waking periods during sleep (W), stages S1 + S2 and S3 + S4 of NREM sleep and REM sleep, at 122 m and after 30 - 41 h of 
acclimatisation at 3480 m.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 1212 56 35 1007 72  −205 0.0001 
  M.R. 3 1051 76 3 817 37  −234 0.0087 
  G.M. 13 1362 81 12 1061 203  −301 0.0001 
  D.C. 140 1026 73 157 779 36  −247 0.0001 
  S.S. 27 1463 224 64 1011 93  −452 0.0001 
  No. of epochs 190         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 1223 102 5 935 88  −278 0.001 
            
S1 + S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 1281 60 34 1123 67  −158 0.0001 
  M.R. 58 1130 55 52 878 41  −252 0.0001 
  G.M. 53 1497 71 54 1236 86  −261 0.0001 
  D.C. 302 1096 43 322 835 28  −261 0.0001 
  S.S. 200 1494 115 237 1197 145  −297 0.0001 
  No. of epochs 658   699      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 1300 69 5 1054 73  −246 0.0001 
            
S3 + S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 1277 48 9 1054 29  −223 0.0001 
  M.R. 11 1121 42 6 833 8  −288 0.0001 
  G.M. 9 1435 113 7 1165 112  −270 0.0003 
  D.C. 98 1065 55 25 846 20  −219 0.0001 
  S.S. 92 1410 65 59 1068 106  −342 0.0001 
  No. of epochs 226   106      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 1262 65 5 993 55  −268 0.001 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 1276 73 5 1128 120  −147 0.0178 
  M.R. 23 1085 69 13 813 25  −272 0.0001 
  G.M. 10 1450 60 13 1106 88  −344 0.0001 
  D.C. 62 1062 56 30 832 40  −231 0.0001 
  S.S. 72 1485 125 52 1069 67  −416 0.0001 
  No. of epochs 175         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 1272 77 5 990 68  −282 0.001 
Footnotes to Table 1: (1)One-way ANOVA tracts analysed in the five mountain runners: the averages of the R-R intervals (ms) measured during the W, S1 + S2, 
S3 + S4 and REM sleep states were significantly different (DF 7,32,39: F-tests = 4.007, P = 0.003). The post-hoc comparison with Fisher analysis showed a 
significant difference (P < 0.05) between the average of the R-R intervals recorded during W at 122 m and that at 3480 m, and a significant difference between 
the average of the R-R intervals recorded during stages S3 + S4 at 3480 m and during REM sleep at 3480 m (P < 0.05). The average of the R-R intervals re-
corded during W at 3480 m differed significantly from that during stages S1 + S2 at 122 m (P < 0.05). Post-hoc comparison with Fisher analysis showed that 
the average of the R-R intervals recorded during stages S3 + S4 at 122 m differed significantly from that during REM sleep at 122 m (P < 0.05). The average of 
the R-R intervals recorded during stages S1 + S2 at 122 m differed significantly from that during stages S1 + S2 at 3480 m (P < 0.05). Post-hoc comparison of 
the average of the R-R intervals recorded during stages S1 + S2 at 122 m differed significantly from that during S3 + S4 and REM sleep at 3480 m (P < 0.05). 
Fisher analysis demonstrated that the average of the R-R intervals recorded during stages S3 + S4 at 3480 m differed significantly from that during REM sleep 
at 122 m (P < 0.05). There was a significant difference between the R-R intervals recorded during REM sleep at 122 m and those during REM sleep at 3480 m 
(P < 0.05). *Post-hoc comparison with Student’s t-test showed that the average of the power of the R-R interval tract analysed in 271 30-second epochs during 
the waking period during sleep (W) at 3480 m was significantly lower (P < 0.05) than the average measured in 699 30-second epochs during stages S1 + S2 of 
NREM sleep at 3480 m in all 5 subjects. 
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Table 2. Averages of the total power of very low frequency (VLF, ms2) (<0.04 Hz) (thermoregulation-related HRV) recorded 
in 30-second signal epochs physiologically defined according to standard criteria developed by Rechtschaffen and Kales 
(1968), during waking periods during sleep (W), stages S1 + S2 and S3 + S4 of NREM and REM sleep, at 122 m and after 30 - 
41 h of acclimatisation at 3480 m in the five subjects.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 26,606 22,461 35 21,496 16,228  −5110 n.s. 
  M.R. 3 38,280 9561 3 22,860 6308  −1542 n.s. 
  G.M. 13 17,791 7300 12 18,278 21,065  487 n.s. 
  D.C. 140 11,102 21,447 157 7610 10,946  −3492 n.s. 
  S.S. 27 18,496 25,566 64 17,749 17,617  −747 n.s. 
  No. of epochs 190   271      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 22,455 17,267 5 17,593 14,433  −4,862 n.s. 
            
S1 + S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 20,578 15,536 34 17,339 12,982  −3239 n.s. 
  M.R. 58 8885 7286 52 8784 9380  −101 n.s. 
  G.M. 53 10,545 9710 54 5979 6471  −4565 0.005
  D.C. 302 2135 2225 322 2348 3088  213 n.s. 
  S.S. 200 8943 16,991 237 7811 8712  −1132 n.s. 
  No. of epochs 658   699      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 10,217 10,350 5 8452 8127  −1765 n.s. 
            
S3 + S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 5264 3352 9 4352 4066  −912 n.s. 
  M.R. 11 4263 3839 6 1943 380  −2320 n.s. 
  G.M. 9 6504 5327 7 4636 5916  −1868 n.s. 
  D.C. 98 1644 1887 25 2233 4700  589 n.s. 
  S.S. 92 2209 3251 59 2730 3263  521 n.s. 
  No. of epochs 226         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 3977* 3531 5 3179** 3665  −798 n.s. 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 29,739 13,936 5 21,703 10,645  −8036 n.s. 
  M.R. 23 20,548 15,408 13 17,039 8214  −3509 n.s. 
  G.M. 10 13,933 5651 13 19,185 8120  5252 n.s. 
  D.C. 62 12,885 23,483 30 13,262 18,141  337 n.s. 
  S.S. 72 7976 9580 52 7637 7406  −339 n.s. 
  No. of epochs 175   113      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 17,016*** 13,612 5 15,765**** 10,505  −1251 n.s. 
Footnotes to Table 2: (1)One-way ANOVA showed that in the five subjects the averages of the total power of very low frequency (VLF, ms2) (<0.04 Hz) (ther-
moregulation-related HRV) differed significantly between stages (DF = 7,32,39; F = 5.15; P < 0.0002). Post-hoc comparison with Fisher analysis of the mean 
revealed a significant difference between the VLF values recorded during W at 122 m and those during stages S1 + S2 at 122 m (P < 0.05), and a significant 
difference between the VLF values recorded during stages S1 + S2 at 3480 m and those during stages S3 + S4 at 122 m and S3 + S4 at 3480 m. There was also 
a significant difference between the mean of the VLF recorded during stages S3 + S4 at 122 m and those during REM sleep at 122 m and at 3480 m (P < 0.05). 
There was a significant difference between the average of the VLF recorded during stages S3 + S4 at 3480 m and those during REM sleep at 122 m and at 3480 
m (P < 0.05). *Post-hoc comparison with Student’S t-test showed that the power in the VLF range of the R-R intervals measured in 190 30-second epochs dur-
ing the waking period during sleep (W) at 122 m was significantly higher (P < 0.0046) than that measured in 226 30-second signal epochs during stages S3 + S4 
of NREM sleep at 122 m in all five subjects. **Post-hoc comparison with Student’s t-test of the mean of the average of the power in the VLF range measured in 
271 30-second epochs during the awakening period during sleep (W) at 3480 m was significantly higher (P < 0.0007) than that measured in 106 30-second 
signal epochs during stages S3+S4 of NREM sleep at 3480 m in all five subjects. ***Post-hoc comparison with Student’s t-test of the mean of the average of the 
power in the VLF range measured in 226 30-second epochs during stages S3 + S4 of NREM sleep at 122 m was significantly lower (P < 0.009) than that meas- 
ured in 175 30-second epochs during REM sleep at 122 m in all five subjects. ****Post-hoc comparison with Student’s t-test of the mean of the average of the 
power in the VLF range measured in 106 30-second epochs during stages S3 + S4 of NREM sleep at 3480 m was significantly lower (P < 0.001) than that 
easured in 113 30-second epochs during REM sleep at 3480 m in all five subjects. m 
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during the awakening period during sleep [(W) (17,593  
14,433)] was significantly longer than the average VLF 
recorded in 106 30-second signal epochs during S3 + S4 
of NREM sleep (3179  3665; P < 0.0007) (Table 2). 
The average VLF in 106 30-second epochs during S3 + 
S4 of NREM sleep (3179  3665) was significantly shor- 
ter than that analyzed in 113 30-second epochs of REM 
sleep (15,765  10,505; P < 0.05).  
Overall, the averaged data recorded during sleep at 
3480 m demonstrate that during the deepening of syn- 
chronized sleep the thermoregulation-related component 
(VLF) of HRV decreased, with a physiological increase 
in vagal tone. During REM sleep the thermoregulation- 
related component of HRV approached that recorded 
during the awakening period during sleep (W) indicating 
an increase in the sympathetic tone . 
3.2.3. Sea Level (122 m) and High Altitude (3480 m) 
The average of the total power of very low frequency 
(VLF, ms2) recorded during S1 + S2 of NREM sleep 
(5979  6471) was significantly shorter at high altitude 
than that recorded sea level (10,545  9710; P < 0.005) in 
only 1/5 (GM) mountain marathon runners (Table 2). 
3.3. Total Power of Low Frequency [(LF, ms2) 
(0.04 - 0.15 Hz)] Range. The LF Appears to 
Have a Widespread Neuronal Genesis and Is 
Considered as a Marker of Sympathetic 
Modulation or a Marker of Both 
Sympathetic and Vagal Modulation 
3.3.1. Sea Level (122 m) 
At 122 m, the averages of LF were: 7997 ms2 during W; 
7400 ms2 during S1 + S2; 4881 ms2 during S3 + S4; and 
8579 ms2 during REM sleep. The changes in the average 
total power in LF were significantly shorter during S3 + 
S4 than those observed during REM sleep (4881  2041 
vs 8579  3473; P < 0.02) (Table 3). These data suggest 
that the average values of LF, a marker of sympathetic 
modulation, decreased during the deepening phases of 
NREM sleep. During REM sleep the average values of 
LF significantly increased, approaching a value similar to 
that observed during W. 
3.3.2. High Altitude (3480 m) 
At 3480 m, the averages of LF were: 6272 ms2 during W; 
7516 ms2 during S1 + S2; 3805 ms2 during S3 + S4; and 
5715 ms2 during REM sleep (Table 3). The results dem- 
onstrate that the average values of LF during sleep at 
altitude did not change significantly between the differ- 
ent sleep stages (Table 3). 
3.3.3. Sea Level (122 m) and High Altitude (3480 m) 
The averages of total power of low frequency (LF ms2) 
recorded at high altitude during W were significantly 
shorter than those recorded at sea level in 3/5 subjects 
[(CS: 3163  1400 at 3480 m vs 5148  3163 at 122 m; P 
< 0.0074); (GM: 6157  2271 at 3480 m vs 9656  2978 
at 122 m; P < 0.0033); (DC: 2774  2056 at 3480 m vs 
5083  4655 at 122 m; P < 0.0001)] (Table 3). The aver- 
age LF recorded during S1 + S2 was significantly longer 
at altitude than that recorded at sea level in 1/5 subjects 
(SS: 17,947  12,895 at 3480 m vs 10,155  6434 at 122 
m; P < 0.0001); the LF was significantly shorter in 2/5 
subjects [(CS: 3539  1734 at 3480 m vs 5946  2294 at 
122 m; P < 0.0001); (MR: 6059  1641 at 3480 m vs 
10,118  2699 at 122 m; P < 0.0001)]; the average LF 
recorded during S3 + S4 was significantly shorter at alti- 
tude than that recorded at 122 m in 2/5 [(CS: 2,276  
2427 at 3480 m vs 3760  1098 at 122 m; P < 0.0455); 
(MR: 3917  592 at 3480 m vs 8344  222 at 122 m; P < 
0.0003)]; the average LF recorded during REM sleep was 
significantly shorter at altitude than that recorded at sea 
level in 3/5 subjects [(MR: 5200  1513 at 3480 m vs 
10159  2790 at 122 m; P < 0.0001); (DC: 3702  1955 
at 3480 m vs 6727  4144 at 122 m; P < 0.0003); (SS: 5, 
140  4402 at 3480 m vs 11,509  6775 at 122 m; P < 
0.0001)]. These data demonstrate great variability in the 
sympathetic LF component of HRV recorded at low and 
high altitudes in the five mountain marathon runners. 
3.4. Low-Frequency in Normalized Units 
[(LFRRNU) (0.04 - 0.15 Hz)] Range. LFRRNU 
Is Considered as a Marker of Sympathetic 
Modulation 
3.4.1. Sea Level (122 m) 
In all 5 subjects, the average LFRRNU recorded in 190 
30-second epochs during the awakening period during 
sleep (W: 73.41  10.15) differed significantly from that 
recorded in 226 30-second epochs during S3 + S4 of 
NREM sleep (64.76  11.45; P < 0.03). In all five moun- 
tain marathon runners, the average LFRRNU during REM 
sleep was significantly longer (74.32  10.17) than that 
observed during S3 + S4 (64.76  11.45; P < 0.0192) 
(Table 4). These data indicate that the marker of sympa- 
thetic modulation (LFRRNU) decreased during deepening 
of sleep. During REM sleep, the average value of LFRRNU 
was similar to that recorded during the awakening period 
during sleep (W), suggesting that both desynchronized 
states were supported by an increase in sympathetic tone. 
3.4.2. High Altitude (3480 m) 
At 3480 m, the average LFRRNU values recorded during 
all four stages of sleep were similar and ranged from 
75.77 during W, 76.25 during S1 + S2, 66.62 during S3 + 
S4, to 80.97 during REM sleep (Table 4).      
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Table 3. Averages of the total power in the low frequency (LF, ms2) (0.04 - 0.15 Hz) range appear to have a widespread neu-
ronal genesis and are considered as a marker of sympathetic modulation or a marker of both sympathetic and vagal modula-
tion. The LF average was calculated in a physiologically defined number of 30-second signal epochs, defined according to the 
standard criteria developed by Rechtschaffen and Kales (1968), recorded during the waking period during sleep (W), stages 
S1 + S2 and S3 + S4 of NREM and REM sleep at 122 m and after 30 - 41 h of acclimatisation at 3480 m in the five subjects.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 5148 2849 35 3163 1400  −1985 0.0074
  M.R. 3 10,477 3742 3 6780 428  −3697 n.s. 
  G.M. 13 9656 2978 12 6157 2271  −3499 0.0033
  D.C. 140 5083 4655 157 2774 2056  −2309 0.0001
  S.S. 27 9619 4825 64 12,485 10,724  2866 n.s. 
  No. of epochs 190   271      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 7997 3810 5 6272 3376  −1725 n.s 
            
S1 + S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 5946 2294 34 3539 1734  −2407 0.0001
  M.R. 58 10,118 2699 52 6059 1641  −4059 0.0001
  G.M. 53 7692 2871 54 6998 2317  −694 n.s 
  D.C. 302 3090 1733 322 3036 1593  −54 n.s 
  S.S. 200 10,155 6434 237 17,947 12,895  7792 0.0001
  No. of epochs 658   699      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 7400 3206 5 7516 4036  116 n.s. 
            
S3 + S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 3760 1098 9 2276 2427  −1484 0.0455
  M.R. 11 8344 2222 6 3917 592  −4427 0.0003
  G.M. 9 4352 1275 7 4274 1504  −78 n.s. 
  D.C. 98 2626 2066 25 2315 1056  −311 n.s. 
  S.S. 92 5324 6544 59 6245 6031  921 n.s. 
  No. of epochs 226   106      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 4881 2,041 5 3805 2322  −1,076 n.s 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 6497 1748 5 6105 2640  −392 n.s. 
  M.R. 23 10,159 2790 13 5200 1513  −4959 0.0001
  G.M. 10 8005 1910 13 8430 2376  425 n.s. 
  D.C. 62 6727 4144 30 3702 1995  −3025 0.0003
  S.S. 72 11,509 6775 52 5140 4402  −6369 0.0001
  No. of epochs 175         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 8579* 3473 5 5715 2585  −2864 n.s 
Footnotes to Table 3: (1)One-way ANOVA revealed no significant changes in the averages of the total power in the low frequency (LF, ms2) (0.04 - 0.15 Hz) 
range (DF 7,32,39, F test 1,3, P = 0,2819). *Post-hoc comparison with Student’s t-test of the average LF value recorded in 175 30-second epochs during REM 
sleep at sea level was significantly higher (P < 0.02) than that recorded in 226 30-second epochs during stages S3 + S4 of NREM sleep at 122 m in all five 
subjects. 
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Table 4. Averages of the total power in the low frequency (0.04 - 0.15 Hz) range in normalized units (LF-RR-NU), which is 
considered as a marker of sympathetic modulation, measured in a physiologically defined number of 30-second signal epochs, 
defined according to the standard criteria developed by Rechtschaffen and Kales (1968), recorded during the waking period 
during sleep (W), stages S1 + S2 and S3 + S4 of NREM and REM sleep at 122 m and after 30 - 41 h of acclimatisation at 3480 
m in the five subjects.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 73.06 6.25 35 76.73 10.05  3.67 n.s. 
  M.R. 3 84.59 7.07 3 84.66 5.94  0.07 n.s. 
  G.M. 13 83.32 5.09 12 60.03 18.26  −23.29 0.0001
  D.C. 140 68.01 19.23 157 74.99 17.52  6.98 0.001 
  S.S. 27 58.06 13.16 64 82.43 13.95  24.37 0.0001
   190   271      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 73.41 10.15 5 75.77 13.14  2.36 n.s. 
            
S1 + S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 66.77 15.70 34 65.03 15.11  −1.73 n.s. 
  M.R. 58 76.41 9.45 52 80.71 6.77  4.30 0.01 
  G.M. 53 78.55 7.91 54 74.44 9.50  −4.11 0.0168
  D.C. 302 55.86 16.23 322 80.61 9.95  24.75 0.0001
  S.S. 200 57.67 17.92 237 80.47 12.71  22.80 0.0001
  No. of epochs 658         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 67.05 13.44 5 76.25 10.81  −9.2 n.s. 
            
S3 + S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 47.27 11.23 9 43.27 27.23  −3.85 n.s. 
  M.R. 11 63.73 12.98 6 73.90 7.93  16.10 0.015 
  G.M. 9 70.19 10.08 7 59.53 11.40  −10.66 n.s. 
  D.C. 98 45.84 16.91 25 74.40 11.30  28.56 0.0001
  S.S. 92 39.52 16.07 59 75.93 8.95  36.41 0.0001
  No. of epochs 226   106      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 64.76* 11.45 5 66.62 13.36  1.86 n.s. 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 67.97 7.94 5 79.53 5.87  11.56 0.01748
  M.R. 23 80.86 5.93 13 89.00 3.82  8.14 0.0001
  G.M. 10 83.83 8.58 13 79.09 7.98  −4.74 n.s. 
  D.C. 62 77.74 12.39 30 87.54 6.38  9.80 0.0001
  S.S. 72 61.18 16.03 52 69.67 17.22  8.49 0.0056
  No. of epochs 175   113      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 74.32** 10.17 5 80.97 8.25  6.65 n.s. 
Footnotes to Table 4: (1)One-way ANOVA revealed significant differences in the averages of the total power in low frequency (0.04 - 0.15 Hz) in normalized 
units (LFRRNU) (DF7,32,39; F = 3,229; P < 0.0105). Post-hoc analysis with Fisher and Scheffé tests revealed that the LF-RR-NU component of the R-R intervals 
during the W state at 122 m differed significantly from than that during stages S3 + S4 (P = 0.05). The LF-RR-NU average values during the W state at 3480 m 
differed significantly from that during stages S3 + S4 (P < 0.05). The LF-RR-NU average during stages S1 + S2 at 122 m differed significantly from that during 
REM sleep at 3480 m (P < 0.05). The LF-RR-NU average during stages S1 + S2 recorded at 3480 m differed significantly from that during stages S3 + S4. The 
LF-RR-NU average during stages S3 + S4 at 122 m differed significantly from that during REM sleep at 122 m (P < 0.05). The LF-RR-NU component of the R-R 
intervals during stages S3 + S4 at 122 m differed significantly from that during REM sleep at 3480 m (P < 0.05). The LF-RR-NU average during stages S3 + S4 
at 3480 m differed from that during REM sleep at 3480 m (P < 0.05) in all five subjects. *Comparison with Student’s t-test showed a significant difference 
between the average of the LF-RR-NU recorded in 190 30-second epochs during the waking period during sleep (W) at 122 m (P < 0.03) and that recorded in 
226 30-second epochs during stages S3 + S4 of NREM sleep at 122 m in all five subjects. **Comparison with Student’s t-test showed a significant difference (P 
 0.0192) between the average of the LF-RR-NU in stages S3 + S4 of NREM sleep and that during REM sleep at 122 m in all five subjects. <    
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3.4.3. Sea Level (122 m) and High Altitude (3480 m) 
The average LFRRNU (Table 4) recorded during W at al- 
titude was significantly shorter than that recorded at sea 
level in 1/5 subjects (GM: 60.03  18.26 at 3480 m vs 
83.32  5.09 at 122 m; P < 0.0001) and significantly 
longer in 2/5 subjects [(DC: 74.99  17.52 at 3480 m vs 
68.01  19.23 at 122 m; P < 0.001); (SS: 82.43  13.95 at 
3480 m vs 58.06  13.16 at 122 m; P < 0.0001)].  
The average LFRRNU recorded during S1 + S2 at high 
altitude was significantly longer than that recorded at sea 
level in 3/5 subjects [(MR: 80.71  6.77 at 3480 m vs 
76.41  9.45 at 122 m; P < 0.01); (DC: 80.61  9.95 at 
3480 m vs 55.86  16.23 at 122 m; P < 0.0001); (SS: 
80.47  12.71 at 3480 m vs 57.67  17.92 at 122 m; P < 
0.0001)], while in 1/5 the average LFRRNU was signifi- 
cantly shorter (GM: 59.53  11.40 at 3480 m vs 70.19  
10.08 at 122 m; P < 0.0168) in S3 + S4. The average 
LFRRNU recorded during S3 + S4 at high altitude was 
significantly longer than that recorded at 122 m in 3/5 
subjects [(MR: 73.90  7.93 at 3480 m vs 63.73  12.98 
at 122 m; P < 0.0150); (DC: 74.40  11.30 at 3480 m vs 
45.84  16.91 at 122 m; P < 0.0001); (SS: 75.93  8.95 at 
3480 m vs 39.52  16.07 at 122 m; P < 0.0001)]. The 
average LFRRNU recorded during REM sleep at high 
altitude was significantly longer than that recorded at 122 
m in 4/5 subjects [(CS: 79.53  5.87 at 3480 m vs 67.97 
 7.94 at 122 m; P < 0.01748); (MR: 89.00  3.82 at 
3480 m vs 80.86  5.93 at 122 m; P < 0.0001); (DC: 
87.54  6.38 at 3480 m vs 77.74  12.39 at 122 m; P < 
0.0001); (SS: 69.67  17.22 at 3480 m vs 61.18  16.03 
at 122 m; P < 0.0056)]. These data show a great variabil- 
ity between mountain marathon runners in LFRRNU when 
the data set recorded at 122 m is compared with that re- 
corded at 3480 m. Analysis of the data recorded in indi- 
vidual mountain marathon runners showed an increase in 
the average LFRRNU at 3480 m, demonstrating an in- 
crease in the marker for sympathetic modulation. 
3.5. Total Power of High Frequency [(HF, ms2) 
(0.15 - 0.4 Hz)] Range. HF Primarily 
Reflects Respiratory-Driven Vagal 
Modulation of Sinus Rhythm 
3.5.1. Sea Level (122 m) 
No significant differences in the averages of HF were 
observed between W (2223  728), S1 + S2 (2945  
1080) and S3 + S4 (3891  1134) and REM (2499  879) 
stages at low altitude (Table 5). The averages of the HF 
recorded during the nocturnal sleep-wake cycle at 122 m 
suggested a prevalence of vagal tone during S3 + S4 
stages in comparison with the other sleep stages. 
3.5.2. High Altitude (3480 m) 
No significant differences in the averages of HF were 
observed between W (1572  993), S1 + S2 (1610  631) 
and S3 + S4 (1480  511) and REM (1159  555) stages 
at 3480 m (Table 5). The averages of the HF recorded 
during the nocturnal sleep-wake cycle at 3480 m sug- 
gested a reduction in vagal tone throughout all sleep 
stages and during awakening during sleep. 
3.5.3. Sea Level (122 m) and High Altitude (3480 m) 
Compared with the values calculated at sea level, there 
was a significant decrease in the average of total power 
of high frequency (HF, ms2) (Table 5) recorded during 
W at altitude in 3/5 subjects [(CS: 1422  384 at 122 m 
vs 743  191 at 3480 m; P < 0.0001); (DC: 1487  729 at 
122 m vs 717  789 at 3480 m; P < 0.0001); (SS: 4849  
1587 at 122 m vs 1674  1179 at 3480 m; P < 0.0001)] 
and a significant increase in 1/5 subjects (GM: 1654  
400 at 122 m vs 3495  2196 at 3480 m; P < 0.0072). 
Compared with the values calculated at sea level, there 
was a significant decrease in the average HF recorded at 
altitude during S1 + S2 of NREM sleep in 4/5 subjects 
[(CS: 2485  1178 at 122 m vs 1513  443 at 3480 m; P 
< 0.0001); (MR: 2892  906 at 122 m vs 1382  546 at 
3480 m; P < 0.0001); (DC: 2167  778 at 122 m vs 605  
297 at 3480 m; P < 0.0001); (SS: 5375  1950 at 122 m 
vs 2640  1385 at 3480 m; P < 0.0001)]. Compared with 
the averages calculated at 122 m, there was a significant 
decrease in the average HF recorded during S3 + S4 of 
NREM sleep at 3480 m in 4/5 subjects [(CS: 3776  982 
at 122 m vs 2044  723 at 3480 m; P < 0.0001); (MR: 
4624  1629 at 122 m vs 975  506 at 3480 m; P < 
0.0001); (DC: 2617  777 at 122 m vs 684  249 at 3480 
m; P < 0.0001); (SS: 6,866  1904 at 122 m vs 1394  
681 at 3480 m; P < 0.0001)] and a significant increase in 
1/5 subjects (GM: 1571  376 at 122 m vs 2303  396 at 
3480 m; P < 0.0021). There was a significant decrease in 
the average HF recorded during REM sleep in 4/5 sub- 
jects [(CS: 2425  531 at 122 m vs 1397  774 at 3480 m; 
P < 0.0155); (MR: 2248  680 at 122 m vs 615  233 at 
3480 m; P < 0.0001); (DC: 1530  708 at 122 m vs 400  
149 at 3480 m; P < 0.0001); (SS: 4885  1559 at 122 m 
vs 1671  1147 at 3480 m; P < 0.0001)]. 
The average HF at 3480 m recorded in individual 
mountain marathon runners was generally lower than that 
recorded at 122 m, suggesting a decrease in the marker of 
vagal tone at altitude. 
3.6. High Frequency in Normalized Units 
[(HFRRNU) (0.04 - 0.15 Hz)]. HFRRNU Is 
Considered as a Marker of Vagal 
Modulation 
3.6.1. Sea Level (122 m) 
In all five subjects, the average of the HFRRNU analyzed        
I. GRITTI  ET  AL. 36 
 
Table 5. Averages of the total power in the high frequency (HF, ms2) (0.15 - 0.4 Hz) range, which primarily reflects respira-
tory-driven vagal modulation of sinus rhythm, in a natural, physiologically defined number of 30-second signal epochs, ac-
cording to the standard criteria developed by Rechtschaffen and Kales (1968), during the waking period during sleep (W), 
stages S1 + S2 and S3 + S4 of NREM and REM sleep measured at 122 m and after 30 - 41 h of acclimatisation at 3480 m in 
the five subjects.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 1422 384 35 743 191  −679 0.0001
  M.R. 3 1701 449 3 1232 612  −469 n.s. 
  G.M. 13 1654 490 12 3495 2196  1841 0.0072
  D.C. 140 1487 729 157 717 789  −770 0.0001
  S.S. 27 4849 1587 64 1674 1179  −3175 0.0001
  No. of epochs 190   271      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 2223 728 5 1572 993  −651 n.s. 
            
S1 + S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 2485 1178 34 1513 443  −972 0.0001
  M.R. 58 2892 906 52 1382 546  −1510 0.0001
  G.M. 53 1807 589 54 1909 484  102 n.s. 
  D.C. 302 2167 778 322 605 297  −1562 0.0001
  S.S. 200 5375 1950 237 2640 1385  −2735 0.0001
  No. of epochs 658   699      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 2945 1080 5 1610 631  1335 n.s. 
            
S3 + S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 3776 982 9 2044 723  −1732 0.0001
  M.R. 11 4624 1629 6 975 506  −3649 0.0001
  G.M. 9 1571 376 7 2303 396  732 0.0021
  D.C. 98 2617 777 25 684 249  −1933 0.0001
  S.S. 92 6866 1904 59 1394 681  −5472 0.0001
  No. of epochs 226   106      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 3891 1134 5 1480 511  −2411 0.04 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 2425 531 5 1397 774  −1028 0.0155
  M.R. 23 2248 680 13 615 233  −1633 0.0001
  G.M. 10 1409 918 13 1711 472  302 n.s. 
  D.C. 62 1530 708 30 400 149  −1130 0.0001
  S.S. 72 4885 1559 52 1671 1147  −1147 0.0001
  No. of epochs 175   113      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 2499 879 5 1159 555  −1340 n.s. 
Footnotes to Table 5: (1)One-way ANOVA revealed a significant difference between stages in the averages of the total power in the high frequency (HF, ms2) 
(0.15-0.4 Hz) range (DF = 732,39; F = 2,576, P = 0,0317). Post-hoc Fisher analysis showed significant differences between the averages of HF during W at 122 
m and during stages S3 + S4 at 122 m (P < 0.05). There was a significant difference between the values measured during W at 3480 m and those during stages 
S3 + S4 at 122 m (P < 0.05). The values measured during stages S1 + S2 at 122 m differed significantly from those during REM sleep at 3480 m in all five 
subjects. 
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in a natural, physiologically defined number of 30-sec- 
ond signal epochs, according to standard criteria de- 
veloped by Rechtschaffen and Kales (1968), during the 
awakening period during sleep (W: 23.47  9.46) was 
significantly shorter than that observed during S3 + S4 of 
NREM at 122 m (56.91  31.14; P < 0.0327). In all five 
subjects, the average of the HFRRNU during S3 + S4 of 
NREM sleep (56.91  31.14) was significantly longer (P 
< 0.01004) than that observed during REM sleep (22.64 
 9.44; P < 0.01004) at 122 m (Table 6). These data sug- 
gest an increase in vagal modulation during the deepen- 
ing of slow-wave NREM sleep and a decrease in vagal 
modulation during the desynchronized awakening period 
during sleep (W) and REM sleep. 
3.6.2. High Altitude (3480 m) 
The average of the HFRRNU analyzed between W (21.31 
 11.08), S1 + S2 (21.52  9.76), S3 + S4 (31.11  12.81) 
of NREM sleep and REM sleep (16.74  6.99) was simi- 
lar (Table 6). The data suggest an increase in vagal mo- 
dulation during S3 + S4 of slow-wave NREM sleep and a 
decrease in vagal modulation during the desynchronized 
awakening period during sleep (W), S1 + S2 of NREM 
sleep and during REM sleep. 
3.6.3. Sea Level (122 m) and High Altitude (3480 m) 
The mean of the averages of the HFRRNU (Table 6) re- 
corded during W at altitude was significantly shorter than 
that recorded at sea level in 2/5 subjects (DC: 22.29  
14.47 at 3480 m vs 30.87  18.75 at 122 m; P < 0.0001); 
(SS: 15.33  11.65 at 3480 m vs 33.4911.57 at 122 m; P 
< 0.0001)] and significantly longer in 1/5 subjects (GM: 
33.15  13.39 at 3480 m vs 15.15  4.6 at 122 m; P < 
0.0001). The mean of the averages of the HFRRNU re- 
corded during S1 + S2 at altitude was significantly shor- 
ter than that recorded at sea level in 3/5 subjects (MR: 
18.81  6.71 at 3480 m vs 23.17  9.48 at 122 m; P < 
0.01); (DC: 18.32  9.43 at 3480 m vs 43.57  16.23 at 
122 m; P < 0.001); (SS: 16.38  10.36 at 3480 m vs 
36.86  17.23 at 122 m; P < 0.0001). The mean of the 
averages of the HFRR-NU recorded during S3 + S4 at al- 
titude was significantly shorter than that recorded at sea 
level in 2/5 subjects [(DC: 24.42  11.04 at 3480 m vs 
53.53  16.73 at 122 m; P < 0.0001); (SS: 22.29  8.30 at 
3480 m vs 55.54  15.78 at 122 m; P < 0.0001)]. The 
mean of the averages of the HFRR-NU recorded during 
REM sleep at altitude was significantly shorter than that 
at sea level in 3/5 subjects [(MR: 10.57  3.76 at 3480 m 
vs 18.50  5.82 at 122 m: P < 0.0001); (DC: 11.56  6.14 
at 3480 m vs 21.80  12.24 at 122 m; P < 0.0001); (SS: 
26.81  14.55 at 3480 m vs 32.15  14.57 at 122 m; P < 
0.04)]. 
3.7. LF:HF Ratio Mirrors Sympathovagal 
Balance or Reflects Sympathetic Modulation 
3.7.1. Sea Level (122 m) 
In all five subjects, the average of the LF:HF ratio during 
W at 122 m was longer (4.6446  2.8655) than that ob- 
served during S3 + S4 (1.6733  1.0847; P < 0.0110) 
(Table 7); the average of the LF:HF ratio during S3+S4 
(1.6733  1.0847) was significantly shorter than that ob- 
served in 175 epochs of REM sleep (4.4739  2.1405; P 
< 0.0113) (Table 7). The data suggest an increase of 
sympathetic modulation during W and REM sleep in 
comparison of synchronized S1 − S4 sleep 
3.7.2. High Altitude (3480 m) 
The average of the LF:HF ratio during S3 + S4 at 3480 m 
(3.2109  1.0873) was significantly lower than that ob- 
served during REM sleep (6.9132  3.6806; P < 
0.036835). The data suggest an increase of sympathetic 
modulation during REM sleep in comparison to synchro- 
nized S3 + S4 sleep. 
3.7.3. Sea Level (122 m) and High Altitude (3480 m) 
The average of the LF:HF ratio (Table 7) during W was 
significantly shorter at 3480 m than at 122 m in 1/5 sub- 
jects (GM: 6.1615  2.4214 at 122 m vs 2.3017  1.3728 
at 3480 m; P < 0.0001) and significantly longer at 3480 
m than at 122 m in 2/5 subjects [(DC: 4.9300  6.2275 at 
122 m vs 7.2334  10.049 at 3480 m; P < 0.0235); (SS: 
2.1570  1.4672 at 122 m vs 9.4181  8.1271 at 3480 m; 
P < 0.0001)]. The average LF:HF ratio during S1 + S2 
was significantly longer at 3480 m than at 122 m in 3/5 
subjects [(MR: 5.0512  2.3613 at 3480 m vs 3.9624  
1.8413 at 122 m; P < 0.0078); (DC: 6.1907  4.3641 at 
3480 m vs 1.7193  1.3779 at 122 m; P < 0.0001); (SS: 
7.9224  6.7405 at 3480 m vs 2.3667  2.16997 at 122 m; 
P < 0.0001)] and significantly shorter in 1/5 subjects 
(GM: 3.9050  1.6255 at 3480 m vs 4.6160  2.0671 at 
122 m; P < 0.0503). The average LF:HF ratio was sig- 
nificantly longer at high altitude than at sea level during 
S3 + S4 in 3/5 subjects [(MR: 4.6867  1.8516 at 3480 m 
vs 2.1655  1.2576 at 122 m; P < 0.0043); (DC: 3.7484  
1.7785 at 3480 m vs 1.2203  1.4342 at 122 m; P < 
0.0001); (SS: 4.0205  2.3448 at 3480 m vs 0.9542  
1.0418 at 122 m; P < 0.0001)]. The average LF:HF ratio 
was significantly longer (P < 0.0102 - 0.0001) during 
REM sleep at high altitude than at sea level in 4/5 sub- 
jects [(CS: 4.7380  1.4928 at 3480 m vs 2.8163  
0.9832 at 122 m); (MR: 9.8554  4.3032 at 3480 m vs 
4.8217  1.5891 at 122 m); (DC: 10.520  6.6211 at 
3480 m vs 5.2563  3.7020 at 122 m); (SS: 4.1387  
3.9490 at 3480 m vs 2.7194  2.0375 at 122 m)]. 
At 122 m and at 3480 m there was a decrease in the 
LF:HF ratio during deepening of NREM sleep, indicating           
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Table 6. Averages of the total power in the high frequency (0.04 - 0.15 Hz) range in normalized units (HFRRNU), which is 
considered as a marker of vagal modulation, in a natural, physiologically defined number of 30-second signal epochs, ac-
cording to standard criteria developed by Rechtschaffen and Kales (1968), during the waking period during sleep (W), stages 
S1 + S2 and S3 + S4 of NREM and REM sleep recorded at 122 m and after 30 - 41 h of acclimatisation at 3480 m in the five 
subjects.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 23.10 6.10 35 21.05 9.79  −2.05 n.s 
  M.R. 3 14.75 6.28 3 15.00 6.08  0.25 n.s. 
  G.M. 13 15.15 4.60 12 33.15 13.39  18.00 0.0001
  D.C. 140 30.87 18.75 157 22.29 14.47  −8.58 0.0001
  S.S. 27 33.49 11.57 64 15.33 11.65  −18.16 0.0001
  No. of epochs 190         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 23.47 9.46 5 21.31 11.08  −2.11 n.s. 
            
S1 + S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 29.29 15.37 34 32.35 14.89  −1.74 n.s 
  M.R. 58 23.17 9.48 52 18.81 6.71  −4.36 0.01 
  G.M. 53 19.97 7.45 54 21.72 7.39  1.75 n.s. 
  D.C. 302 43.57 16.23 322 18.32 9.43  −25.24 0.001 
  S.S. 200 36.86 17.23 237 16.38 10.36  −20.48 0.0001
  No. of epochs 658   699      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 30.57 13.15 5 21.52 9.76  −9.06  
            
S3 + S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 47.99 11.84 9 55.07 26.98  7.08 n.s 
  M.R. 11 35.90 12.94 6 19.53 8.02  −16.38 n.s 
  G.M. 9 26.50 7.55 7 34.26 9.97  7.76 n.s 
  D.C. 98 53.53 16.73 25 24.42 11.04  −29.11 0.0001
  S.S. 92 55.54 15.78 59 22.29 8.30  −36.4 0.0001
  No. of epochs 226   106      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 56.91* 31.14 5 31.11 12.81  −25.80 n.s 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 26.43 8.12 5 17.87 4.31  −8.56 n.s. 
  M.R. 23 18.50 5.82 13 10.57 3.76  −7.93 0.001 
  G.M. 10 14.31 6.46 13 16.91 6.18  2.60 n.s. 
  D.C. 62 21.80 12.24 30 11.56 6.14  −10.24 0.0001
  S.S. 72 32.15 14.57 52 26.81 14.55  −5.34 0.0461
  No. of epochs 175   113      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 22.64** 9.44 5 16.74 6.99  −5.90 n.s. 
Footnotes to Table 6: (1)One-way ANOVA of the averages of the total power in the high frequency (0.04 - 0.15 Hz) range in normalized units (HF-RR-NU) 
showed significant differences between conditions (DF7,32,39; F 4071; P < 0.0027). Post-hoc analysis demonstrated a significant difference between the average 
HF-RR-NU during W at 122 m and that during stages S3 + S4 at 122 m (P < 0.05). The averages of HF-RR-NU during W at 3480 m differed significantly from 
those during stages S3 + S4 at 122 (P < 0.05). The averages of HF-RR-NU during W at 122 m differed significantly from those during stages S3 + S4 at 122 m 
(P < 0.05). The average of HF-RR-NU during stages S1 + S2 at 122 m differed significantly from that during stages S3 + S4 at 3480 m (P < 0.05). The average 
of HF-RR-NU during stages S1 + S2 at 3480 m differed significantly from that during stages S3 + S4 at 122 m (P < 0.05). The average of HF-RR-NU during 
stages S3 + S4 at 122 m differed significantly from that during stages S3 + S4 at 3480 m (P < 0.05). The average of HF-RR-NU during stages S3 + S4 at 122 m 
differed significantly from that during REM sleep at 122 m (P < 0.05); The average of HF-RR-NU during stages S3 + S4 at 122 m differed significantly from 
that during stages S3 + S4 at 3480 m (P < 0.05); The average of HF-RR-NU during stages S3 + S4 at 3480 m differed significantly from that during REM sleep 
at 3480 m (P < 0.05) in all five subjects. *Comparison with Student’s t-test of the average of the HF-RR-NU, in a natural, physiologically defined number of 
30-second signal epochs, according to standard criteria developed by Rechtschaffen and Kales (1968), during the waking period during sleep (W) differed 
significantly from that during stages S3 + S4 of NREM sleep at 122 m in all five subjects (P < 0.0327). **Comparison with Student’s t-test of the average of the 
HF-RR-NU, in a natural, physiologically defined number of 30-second signal epochs, according to standard criteria developed by Rechtschaffen and Kales 
(1968), during stages S3 + S4 of NREM sleep differed significantly from that during REM sleep at 122 m in all five subjects (P < 0.01004). 
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Table 7. Averages of the ratio of low frequency/high frequency (LF, ms2/HF, ms2) range, which mirrors sympathovagal bal-
ance or reflects sympathetic modulation, in a physiologically defined number of 30-second signal epochs, according to stan-
dard criteria developed by Rechtschaffen and Kales (1968), during the waking period during sleep (W), stages S1 + S2 and S3 
+ S4 of NREM sleep and REM sleep at 122 m and after 30 - 41 h of acclimatisation at 3480 m in the five subjects.(1) 
Stages  Subjects 122 m 3480 m    
   Epochs   Epochs      
Awakening during sleep   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 7 3.47 1.4415 35 4.5477 2.2645  1.0777 n.s. 
  M.R. 3 6.513 2.77 3 6.517 3.324  0.004 n.s. 
  G.M. 13 6.1615 2.4214 12 2.3017 1.3728  −3.8598 0.0001
  D.C. 140 4.93 6.2275 157 7.2334 10.049  2.3034 0.0235
  S.S. 27 2.157 1.4672 64 9.4181 8.1271  7.2611 0.0001
  No. of epochs 190   271      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 4.6446 2.8655 5 6.0036 5.0276  1.357 n.s. 
            
S1+ S2   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 45 2.9293 1.5299 34 2.5515 1.3856  −0.3778 n.s. 
  M.R. 58 3.9624 1.8413 52 5.0512 2.3613  1.0888 0.0078
  G.M. 53 4.616 2.0671 54 3.905 1.6255  −0.711 0.0503
  D.C. 302 1.7193 1.3779 322 6.1907 4.3641  4.4714 0.0001
  S.S. 200 2.3667 2.1697 220 7.9224 6.7405  5.5557 0.0001
  No. of epochs 658   683      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 3.1187 1.7972 5 5.1242 3.2954  2.007 n.s. 
            
S3+ S4   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 16 1.0919 0.477 9 1.6633 2.2308  0.5714 n.s. 
  M.R. 11 2.1655 1.2576 6 4.6867 1.8516  2.5212 0.0043
  G.M. 9 2.9344 1.2127 7 1.9357 0.831  −0.9987 n.s. 
  D.C. 98 1.2203 1.4342 25 3.7484 1.7785  2.5281 0.0001
  S.S. 92 0.9542 1.0418 59 4.0205 2.3448  3.25 0.0001
  No. of epochs 226         
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 1.633* 1.0847 5 3.2109 1.8073  1.538 n.s. 
            
REM   Epochs   Epochs      
   N. Mean S.D. N. Mean S.D.  Delta P value
  C.S 8 2.81163  5 4.738 1.4928  1.9217 0.0166
  M.R. 23 4.82217  13 9.8554 4.3032  5.0337 0.0001
  G.M. 10 6.756  13 5.3138 2.0368  −1.4422 n.s. 
  D.C. 62 5.2563  30 10.52 6.6211  5.264 0.0001
  S.S. 72 2.7194  52 4.1387 3.949  1.493 0.0102
  No. of epochs 175   113      
   No. of subjects Mean S.E.M. No. of subjects Mean S.E.M.  Delta  
     subjects   subjects    
  Average 5 4.4739**  5 6.9132*** 3.6806  2.439 n.s. 
Footnotes to Table 7: (1)One-way ANOVA showed no significant differences in the LF/HF ratio in the different conditions. *Student’s t-test showed that the 
average of the total power of the LF/HF ratio during the waking state during sleep (W) (190 epochs) at 122 m was generally higher than the average LF/HF 
ratio during stages S3 + S4 (226 epochs) at the same altitude in the five subjects (P < 0.0110). **Student’s t-test showed that the average of the total power of 
the LF/HF ratio during stages S3 + S4 in a total of 226 epochs of 30 seconds at low altitude was significantly lower  than that in 175 epochs of REM sleep at 
122 m in the five subjects (P < 0.011335). ***Student’s t-test showed that the average of the total power of the LF/HF ratio during stages S3 + S4 (106 epochs) 
t 3480 m was significantly lower than that during REM sleep (113 epochs) at high altitude in the five subjects (P < 0.036835). a    
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a decline in sympathovagal balance. At 122 m and at 
3480 m the average values of LF:HF during REM sleep 
were similar to those observed during the awakening 
period during sleep (W). 
3.8. Total Power (TP, ms2) 
3.8.1. Sea Level (122 m) 
The average of the TP during the awakening period dur-
ing sleep (W: 33,057  18,136) differed significantly 
from that recorded during S3 + S4 (13,007  4621; P < 
0.0068). During S3 + S4 of NREM sleep (13,007  4621), 
the average of the TP differed significantly from that 
observed during REM sleep (28,480  14,192; P < 
0.003341) (Table 8). The TP during REM sleep was 
similar to the TP values recorded during W. 
3.8.2. High Altitude (3480 m) 
During S3 + S4 of NREM sleep (9202  3805), the av-
erage of the TP differed significantly from that observed 
during REM sleep (22,838  11,600; P < 0.002613) in all 
five subjects. 
3.8.3. Sea Level (122 m) and High Altitude (3480 m) 
(Table 8) 
During W, the average of the total power (TP, ms2) re- 
corded at 122 m was longer than that recorded at 3480 m 
in 2/5 subjects [(MR: 50,528  7837 at 122 m vs 30,899 
at 3480 m; P < 0.0254); (DC: 17,740  23,122 at 122 m 
vs 11,197  11,829 at 3480 m; P < 0.0020)] (Table 8). 
During S1 + S2 the average of the TP at low altitude was 
significantly longer than that observed at 3480 m in 3/5 
subjects [(MR: 21,950  8436 at 122 m vs 16,258  9971 
at 3480 m; P < 0.0015); (GM: 20,200  11,240 at 122 m 
vs 15,218  7421 at 3480 m; P < 0.0079); (DC: 7240  
2998 at 122 m vs 6021  3589 at 3480 m; P < 0.00019)]. 
During S3 + S4 the average of the TP at 122 m was sig- 
nificantly longer than that observed at 3480 m in 4/5 sub- 
jects (CS: 13,176  3660 at 122 m vs 8733  5824 at 
3480 m; P < 0.0275); (MR: 17,278  4805 at 122 m vs 
6865  720 at 3480 m; P < 0.0001); (DC: 6917  3007 at 
122 m vs 5262  4686 at 3480 m; P < 0.0307) (SS: 
15,005  5017 at 122 m vs 10,516  9526 at 3480 m; P < 
0.0002). At 3480 m during the awakening period during 
sleep (W: 25,672  15,424), the average of the TP dif- 
fered significantly from that recorded during S3 + S4 
(9202  3805; P < 0.028). The average of the TP re- 
corded during REM sleep at sea level was significantly 
shorter than that at altitude in 2/5 subjects (CS: 39,198  
13,892 at 122 m vs 22,879  8,514 at 3480 m; P < 
0.0320); (SS: 25,442  11,874 at 122 m vs 14,723  7978 
at 3480 m; P < 0.0001).  
At 122 m and at 3480 m, there was a decrease in TP 
during deepening of NREM sleep. At 122 m and at 3480 
m, the average values of TP during REM sleep were simi- 
lar to those observed during awakening during sleep (W).  
4. Discussion 
Fluctuations in autonomic cardiovascular regulation dur- 
ing exposure to high-altitude environment may increase 
the risk of heart attack. This study compared heart rate 
variability (HVR) and its components during sleep: at 
low altitude and after 30 - 41 hours of acclimatization at 
high altitude (3480 m) in mountain marathon runners 
controlled for diet, drugs, light-dark cycle and jet lag dif- 
ferences. At altitude, RR-intervals became significantly 
shorter (P < 0.001). The significant changes in sympa- 
thetic/parasympathetic autonomic cardiovascular modu- 
lation at high altitude can protect against excessive oxy- 
gen deprivation, particularly during sleep, and thus lower 
the risk of heart attack. Increase in R-R intervals during 
wake and sleep may require longer periods of acclimati-
zation at 3480 m to mitigate the effects of altitude/hypo- 
xia on the sympathetic tone of the mountain marathon 
runners, thus reducing cardiovascular distress. 
5. Background 
Molecular oxygen is essential for all higher forms of life 
and brain cell function. During evolution, humans and 
other animal species developed molecular, biochemical 
and physiological mechanisms to optimize oxygen utili- 
zation efficacy. Humans respond to acute or chronic ex- 
posure to hypobaric-hypoxia by resetting the pO2 balance 
to ensure brain and heart cell function. Understanding 
how the body adjusts its biochemical and physiological 
cellular needs may help to better define the health risks 
associated with activities in hypobaric-hypoxia condi- 
tions and can aid in identifying appropriate therapeutic 
non-pharmacological and/or pharmacological treatments. 
Our ability to breathe and to modify breathing according 
to the amount of available ambient oxygen and to our 
body’s demands (particularly those of the brain, heart 
and lungs) is essential for survival. Failure to breathe or 
an inadequate oxygen supply, especially to the brain, 
contributes to cardiorespiratory distress. In hypoxic con- 
ditions, distribution of cardiac output to the cardiovascu- 
lar beds is subordinate to a preprogrammed priority pro- 
gram for preservation of the organism. In hypoxic condi- 
tions, the majority of neuronal systems of the brain in- 
crease and/or change their firing rate in order to modulate 
in a cyclic manner the discharge of the neurons involved 
in regulating the oxygen supply in mammals [15,16,18, 
19]. 
Acute and chronic exposure to hypoxemia leads to all 
sorts of disturbances that suggest impaired excitatory 
neuronal functions involved in the behavioral and meta- 
bolic integration of autonomi  control and arousal [15].  c  
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Table 8. Averages of the total power (TP, ms2) in a physiologically defined number of 30-second EEG signal epochs, accord-
ing to standard criteria developed by Rechtschaffen and Kales (1968), during the waking state during sleep (W), stages S1 + 
S2 and S3 + S4 of NREM sleep and REM sleep at 122 m and after 30 - 41 h of acclimatisation at 3480 m in the five subjects. 
Stages Subjects 122 m 3480 m   
  Epochs   Epochs     
Awakening during sleep  N. Mean S.D. N. Mean S.D. Delta P value
 C.S 7 33,449 24,257 35 25,486 16,753 −7963 n.s. 
 M.R. 3 50,528 7837 3 30,899 5845 −19,629 0.0254
 G.M. 13 29,277 9809 12 28,573 22,336 −704 n.s. 
 D.C. 140 17,740 23,122 157 11,197 11,829 −6543 0.002 
 S.S. 27 34,293 25,655 64 32,203 20,358 −2090 n.s. 
 No. of epochs 190   271     
  No. of subjects Mean S.E.M. No. of subjects Mean S.E.M. Delta  
    subjects   subjects   
 Average 5 33,057 18,136 5 25,672 15,424 −7385 n.s. 
S1+ S2  Epochs   Epochs     
  N. Mean S.D. N. Mean S.D. Delta P value
 C.S 45 29,292 16,380 34 22,533 13,712 −6758  
 M.R. 58 21,950 8436 52 16,258 9971 −5692 n.s. 
 G.M. 53 20,200 11,240 54 15,218 7421 −4982 0.0015
 D.C. 302 7420 2998 322 6021 3589 −1398 0.0079
 S.S. 200 25,316 18,423 237 29,006 16,917 3690 0.0001
 No. of epochs 658   683    0.0297
  No. of subjects Mean S.E.M. No. of subjects Mean S.E.M. Delta  
    subjects   subjects   
 Average 5 20,836 11,495 5 17,807 10,322 −3028 n.s 
S3+ S4  Epochs   Epochs     
  N. Mean S.D. N. Mean S.D. Delta P value
 C.S 16 13,176 3660 9 8733 5824 −4443 0.0275
 M.R. 11 17,278 4805 6 6865 720 −10,412 0.0001
 G.M. 9 12,659 6614 7 11,634 6801 −1025 n.s. 
 D.C. 98 6917 3007 25 5262 4686 −1655 0.0307
 S.S. 92 15,005 5017 59 10,516 9526 −4489 0.0002
 No. of epochs 226   106     
  No. of subjects Mean S.E.M. No. of subjects Mean S.E.M. Delta  
    subjects   subjects   
 Average 5 13,0007* 4621 5 9202** 3805 −3798 n.s. 
REM  Epochs   Epochs     
  N. Mean S.D. N. Mean S.D. Delta P value
 C.S 8 39,198 13,892 5 29,459 13,908 −938 n.s. 
 M.R. 23 33,035 14,907 13 22,879 8514 −10,156 0.032 
 G.M. 10 23,552 6159 13 29,734 9673 6182 n.s. 
 D.C. 62 21,174 24,128 30 17,396 17,929 −3778 n.s. 
 S.S. 72 25,442 11,874 52 14,723 7978 10,719 0.0001
 No. of epochs 175   113     
  No. of subjects Mean S.E.M. No. of subjects Mean S.E.M. Delta  
    subjects   subjects   
 Average 5 28,480*** 14,192 5 22,838**** 116,000 −5642 n.s. 
Footnotes to Table 8: (1)One-way ANOVA showed a significant difference in the average of the total power (TP) between conditions (DF 7,32,39; F = 5433; P = 
0.0004). Post-hoc Fisher analysis revealed a significant difference between the average of the TP recorded at 122 m during waking (W) and that recorded at 122 
m during stages S1 + S2 (P < 0.05)and during stages S3 + S4 (P < 0.05). Post-hoc Fisher analysis revealed a significant difference between the average of the 
TP recorded at 122 m during waking (W) and that at 3480 m during stages S1 + S2 (P < 0.05) and stages S3 + S4 (P < 0.05). Post-hoc Fisher analysis revealed a 
significant difference between the average of the TP recorded at 122 m during waking (W) and that at 3480 m during REM sleep (P < 0.05). Post-hoc Fisher 
analysis revealed a significant difference between the average of the TP recorded at 3480 m during stages S3 + S4 and that at 122 m during stages S3 + S4 (P < 
0.05). Post-hoc Fisher analysis revealed a significant difference between the average of the TP recorded at 122 m during stages S1 + S2 and that at 3480 m dur- 
ing REM sleep (P < 0.05). Post-hoc Fisher analysis revealed a significant difference between the average of the TP recorded at 3480 m during stages S1 + S2 
and that at 122 m during REM sleep (P < 0.05). Post-hoc Fisher analysis revealed a significant difference between the average of the TP recorded at 122 m 
during stages S3 + S4 and that at 122 m during REM sleep (P < 0.05). Post-hoc Fisher revealed a significant difference between the average of the TP recorded 
at 3480 m during stages S3 + S4 and that at 122 m during REM sleep (P < 0.05). Post-hoc Fisher analysis revealed a significant difference between the average 
of the TP recorded at 3480 m during stages S3 + S4 and that at 3480 m during REM sleep (P < 0.05) in the five subjects. *Post-hoc analysis with Student’s t-test 
showed a significant difference (P < 0.05) between the average of the total power (TP, ms2), in a physiologically defined number of 30-second signal epochs, 
according to standard criteria developed by Rechtschaffen and Kales (1968), recorded during the waking state during sleep (W) (190 epochs) and that during 
stages S3 + S4 (226 epochs) at 122 m (P < 0.0068) in the five subjects. **Post-hoc analysis with Student’s t-test showed a significant difference (P < 0.028) 
between the average of the total power (TP, ms2), in a physiologically defined number of 30-second signal epochs, according to standard criteria developed by 
Rechtschaffen and Kales (1968), recorded during the waking state during sleep (W) (271 epochs) and that during stages S3 + S4 (106 epochs) at 3480 m in the 
five subjects. ***Post-hoc analysis with Student’s t-test showed a significant difference (P < 0.003341) between the average of the total power (TP, ms2), in a physio-
logically defined number of 30-second signal epochs, according to standard criteria developed by Rechtschaffen and Kales (1968), recorded during stages S3 + S4 
(226 epochs) and that during REM sleep (175 epochs) at 122 m in the five subjects. ****Post-hoc analysis with Student’s t-test showed a significant difference (P < 
0.002613) between the average of the total power (TP, ms2), in a physiologically defined number of 30-second signal epochs, according to standard criteria devel-
ped by Rechtschaffen and Kales (1968), recorded during stages S3 + S4 (106 epochs) and that during REM sleep (113 epochs) at 3480 m in the five subjects. o     
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Research into the causes of cardiovascular mortality, ex- 
perimental evidence for a predisposition to fatal arrhyth- 
mias, signs of tonic or phasic increased sympathetic ac- 
tivity, and reduced parasympathetic-cholinergic-vagal ac- 
tivity has advanced efforts for the development of quan- 
titative markers of heart rate variability (HRV) (Task 
Force, [1]). 
5.1. Heart Rate Variability during Wake and 
Sleep 
HRV has been established as a non-invasive tool to study 
cardiac autonomic activity and proposed as a predictor 
for evaluating the increased risk of cardiac death. Inter- 
actions of changes in cardiac autonomic nervous modu- 
lation in various types of subjects are under study by the 
Task Force [1]. An overnight declining trend of HRV has 
been found to increase during sleep [14]. Otzenberger and 
co-workers [14] demonstrated that overnight profiles of 
the R-R intervals are related to changes in the sleep EEG 
mean frequency sign, which reflects the depth of sleep. 
During attentive-to-quiet waking and from the lighter to 
the deeper phases of sleep, HRV has been shown to be 
affected by vagal/sympathetic modulation and control.  
5.2. Heart Rate Variability and Mountain 
Marathon Runners 
Past studies showed that the high-altitude endurance per- 
formance of mountain marathoners is appreciably re- 
duced at 5200 m. Based on their clinical characteristics, 
mountain marathoners can be considered as a physio- 
logical model for studying cardiovascular alterations, of 
long-lasting stay and exercise at high altitude. Over the 
last 12 years, the time course of cardiovascular changes 
in the mountain marathon runners has been assessed be- 
fore, during, and after the end of races at altitude. In sea- 
level native mountain marathoners, long-lasting training 
—from sea level to altitude—can lower the HR, during 
rest and exercise, associated with a decrease in sympa- 
thetic modulation and a rise in parasympathetic activity 
[20]. As in normal subjects, so too in well-trained moun- 
tain marathoners cardiovascular modifications can change 
continuously over a 24-h period during acclimatization 
and the nocturnal sleep-wake- cycle at low and high alti- 
tudes. In mountain marathoners, just as in normal sub- 
jects, HRV alterations at altitude may include altered 
resting HR due to changes in the vagal and sympathetic 
components, besides the appearance of sinus arrhythmia 
during waking and periodically during nocturnal S1 + S2 
NREM sleep and REM sleep breathing. 
As suggested by the Task Force [1], the present study 
data were obtained during sleep and as such may add 
valuable insights for research into HRV. With this study 
we also wanted to determine whether 20 years of training 
between 122 m and 5200 m altitude could have exerted, 
in addition to the changes reported elsewhere [9,12], a 
high impact on the autonomic/cardiovascular systems of 
the mountain marathon runners during the nocturnal sleep- 
wake cycle at low and at high altitudes. 
Our study documents that, in mountain marathoners, 
the nocturnal sleep-wake cycle at 122 m is highly influ- 
ence by autonomic parasympathetic activity and by in- 
creased autonomic parasympathetic activity during the 
deepening of NREM sleep. The results also show a phy- 
siological decrease in parasympathetic activity versus an 
increase in sympathetic activity during all phases of the 
nocturnal sleep-wake cycle at 3480 m. Surprisingly, our 
study also documents that the nocturnal sleep-wake cycle 
at 3480 m is still characterized by an increase in auto- 
nomic parasympathetic activity during light S1 + S2 
NREM sleep. At both altitudes, the trend of the balance 
of parasympathetic/sympathetic activity recorded during 
REM sleep is similar to that recorded during the awak- 
ening state (W). 
5.3. R-R Intervals (ms) 
5.3.1. Sea Level (122 m) 
The averages of the R-R intervals recorded at 122 m did 
not change significantly between nocturnal awakenings 
during sleep and sleep stages (R-R interval range, 1200 - 
1300 ms). The average R-R interval at 122 m, during the 
awaking state of sleep, was similar to that recorded dur- 
ing the wake state in 12 trained endurance athletes who 
performed a minimum of 3 h of aerobic activity per week 
[21].  
5.3.2. High Altitude (3480 m) 
The majority of the ECG alterations in the five mountain 
runners, during sleep at an altitude of 3480 m and at a 
barometric pressure (PB) of 495 mm Hg, and between 30 
and 41 h of acclimatization were: signs of sinus arrhyth- 
mia during the early stages (S1 + S2) of NREM sleep and 
during REM sleep. At 3480 m, the average of the R-R 
intervals we recorded during S1 + S2 of NREM sleep 
were significantly longer than those observed during the 
awaking period (W) during sleep. The longest average 
R-R intervals were recorded during S1 + S2 at 3480 m. 
These results suggest that, at altitude, there was still a 
significant elevation of parasympathetic tone during S1 + 
S2 of slow-wave sleep versus the waking state during 
sleep at 3480 m.  
5.3.3. Sea Level (122 m) and High Altitude (3480 m) 
There was a nonpathological, significant reduction in the 
R-R intervals during the awakening period during sleep 
(W), S1 + S2, S3 + S4 of NREM and REM sleep stages, 
and after 30 - 41 h of acclimatization to an altitude of 
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3480 m, versus the averages of the R-R intervals ob- 
served during the same stages at 122 m. 
The longest average R-R intervals were recorded dur- 
ing the light stage of slow-wave-sleep (S1 + S2) at 122 m 
(suggesting high vagal activation), and the lowest aver- 
age R-R intervals were recorded during the awakening 
period during sleep (W) at 3480 m (indicating an in- 
crease in noradrenergic activation). Overall, the average 
R-R intervals at high altitude were significantly lower 
than those recorded at 122 m, with the average R-R in- 
tervals we recorded at 3480 m, even during the awaken- 
ing period (W) during sleep (935 ms). The absolute value 
of the R-R intervals Bernardi and co-workers [22] found 
in 10 sea-level native subjects at low altitude was 1002  
45 ms and 809  116 ms in 3 high-altitude native sub- 
jects living at low altitude. In that study, the average R-R 
intervals in the 10 sea-level native subjects and in 3 high- 
altitude native subjects (living at low altitude) exposed to 
4970 m for 3 days were 775  57 and 749  47, respec- 
tively. The delta of the averages of the R-R intervals that 
we calculated in our subjects after exposure to 3480 m 
was similar to the delta of the R-R intervals Bernardi and 
co-workers [22] reported. In our study, the average R-R 
intervals recorded at 122 m and 3480 m, during all sleep 
stages, were also longer than those observed by Lanfran- 
chi and co-workers [2] in 41 mountaineers, during wak- 
ing, with and without AMS, and after acute exposure to 
approximately 4500 m. Overall, the average R-R inter- 
vals we recorded at 122 m and 3480 m demonstrate that 
frequent exposure to altitudes between 122 m and 5500 
m, for more than 20 years, may have improved the effi- 
cacy of vagal modulation at low and high altitude during 
nocturnal awakening and sleep. 
5.4. Simple Linear Regression Analysis between 
the R-R Intervals and the %SpaO2 
Linear regression analysis showed a significant negative 
correlation between the changes in the average %SpaO2 
and the changes in the average R-R intervals. The sig- 
nificant negative correlation between %SpaO2 and R-R 
intervals may indicate that the average quantity of oxy- 
gen supplied during nocturnal sleep stages may be di- 
rectly responsible for the R-R interval changes observed 
during nocturnal sleep, particularly at high altitude. 
5.5. Total Power of Very Low Frequency [(VLF, 
ms2) (<0.04 Hz)] Such as the 
Thermoregulation-Related HRV 
The thermoregulatory-related very low frequency (VLF) 
rhythm may be related to thermoregulatory changes or 
chemical and acid-base equilibrium changes, or both. In- 
terestingly, the changes in the VLF are significantly co- 
related with the PCO2 changes (personal observations, 
DF1,38,39; R-squared = 0.191; coefficient = –9702.94; Ftest 
= 8.982; P = 0.0048; t = 1.146); tCO2 changes (personal 
observations, DF 1,38,39; R-squared = 0.189; coefficient = 
–21649.785; Ftest = 8.871; P = 0.005; t = 2.978); and 
3HCO
  changes (personal observations, DF1,38,39; R- 
squared = 0.184; coefficient = –21682.826; Ftest = 8.557; 
P = 0.0058; t = 2.925) 
5.5.1. Sea Level (122 m) 
At 122 m, the average VLF decreased during S1 + S2, 
and significantly so during S3 + S4, compared with the 
average VLF recorded during the waking period (W). 
The average VLF during S3 + S4 at 122 m was signifi- 
cantly shorter than the average VLF recorded during the 
awakening period (W) during sleep. The average VLF 
during S3 + S4 at 122 m was shorter than the average 
VLF recorded during REM sleep. At 122 m, there was a 
decrease in the average VLF during NREM sleep and an 
increase in VLF during the desynchronized waking state. 
The average VLF during desynchronized REM sleep at 
122 m was slightly shorter than the average VLF re- 
corded during the awakening period (W) during sleep.  
5.5.2. High Altitude (3480 m)  
At 3480 m, the average VLF decreased during S1 + S2, 
and significantly so during S3 + S4, compared with the 
average VLF recorded during the awaking period (W) 
during sleep. The average VLF during S3 + S4 at 3480 m 
was significantly shorter than the average VLF recorded 
during the awakening period (W) during sleep. At 3480 
m, there was a decrease in the average VLF during 
NREM sleep and an increase during the desynchronized 
awaking state during sleep and REM sleep. The average 
VLF during REM sleep at 3480 m was slightly shorter 
than that observed during the awakening period (W) dur- 
ing sleep.  
5.5.3. Sea Level (122 m) and High Altitude (3480 m) 
The average VLF during the awakening period (W) dur- 
ing sleep, S1 + S2, S3 + S4, and REM sleep at 122 m 
was longer, but not significantly so, compared with the 
average VLF observed at 3480 m. 
5.6. Total Power of Low Frequency [(LF, ms2) 
(0.04 - 0.15 Hz)] Range. The LF Appears to 
Have a Widespread Neuronal Genesis and Is 
Considered as a Marker of Sympathetic 
Modulation or a Marker of Both 
Sympathetic and Vagal Modulation 
5.6.1. Sea Level (122 m)  
Statistical analysis of our data revealed that the average 
of the LF during desynchronized REM sleep at 122 m 
was significantly longer than that recorded during syn- 
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chronized S3 + S4 sleep. These data demonstrate an in- 
crease in parasympathetic tone during REM sleep. 
5.6.2. High Altitude (3480 m) 
In altitude there was a significant increase in sympathetic 
tone throughout the awakening period (W) during sleep, 
the S1 + S2, and the REM sleep. The sympathetic tone 
decreased during the deep phase of slow wave sleep (S3 
+ S4). 
5.6.3. Sea Level (122 m) and High Altitude (3480 m) 
No significant changes were found between the average 
LF recorded at 122 m and that recorded at 3480 m. How- 
ever, in some subjects, a significant decrease emerged 
between the average of LF recorded during the awaken- 
ing period (W) during sleep, S1 + S2, S3 + S4, and REM 
sleep at 122 m versus the average of LF recorded at 3480 
m. 
The average LF recorded in all 5 mountain marathon- 
ers and in all 4 stages of desynchronization and synchro- 
nization at 122 m and at 3480 m (Table 3) were longer 
than the average LF Ako and co-workers [3] observed in 
7 subjects during sleep at sea level. 
We also found a decrease in the average LF during S3 
+ S4 at 122 m and 3480 m compared with the average LF 
recorded during S1 + S2. The average LF recorded in our 
study during the desynchronized REM sleep state, at 122 
m and 3480 m, returned to similar values we recorded 
during the desynchronized awakening period (W) during 
sleep. A comparison of LF indices in the different sleep 
stages recorded at 122 m and at 3480 m revealed a de-
crease in the LF from the waking to the deep stages of 
sleep. The average LF during REM sleep was similar to 
the average LF recorded during waking. Like those of 
Ako and co-workers [3], our data suggest that sympa- 
thetic nervous activity decreases as sleep deepens and 
concomitantly increases during desynchronization of the 
awakening period (W) during sleep and even more so 
during desynchronization during REM sleep. In our study, 
the average LF, a marker of sympathetic modulation, 
during the awakening period (W) during sleep, S1 + S2, 
S3 + S4, and REM sleep at 122 m and at 3480 m was 
lower.  
5.7. LFRRNU 
The aim of this study was also to verify whether auto- 
nomic variables at low altitude could predict prodromic 
signs of AMS when subjects were exposed to high alti- 
tude or whether subjects experienced AMS at high alti- 
tude. Autonomic cardiovascular function was also ex- 
plored by measuring widespread neuronal genesis rhythm 
low frequency in normalized unit (LFRRNU) to study 
sympathetic modulation. 
Lanfranchi and co-workers [2] reported a substantial 
increase in the LFRRNU component at altitude, suggest- 
ing an increase in sympathetic modulation in response to 
hypoxia at 4500 m. During exposure to high altitude, 
besides shorter R-R intervals, we also found a relative, 
though not significant, increase in the LFRRNU compo- 
nent. 
We agree with Lanfranchi and co-workers [2] that this 
increase in the LFRRNU component may reflect an in- 
crease in the sympathetic modulation of HR. During ex- 
posure to 3480 m, R-R interval variability decreased as 
the LF component increased, suggesting an increase in 
sympathetic modulation in response to hypobaric-hypo- 
xia. The average LFRRNU Lanfranchi and co-workers [2] 
recorded in 24 subjects without AMS after exposure to 
approximately 4500 m during waking was similar to the 
average we recorded in our subjects during the awaken- 
ing period (W) during sleep at 3480 m (73 vs 75, respec- 
tively). 
LFRRNU has been said to be a quantitative marker of 
the cardiac vigil (Vanderwalle et al. [23]) and sympa- 
thetic outflow of the autonomic nervous system. By 
means of spectral analysis of subjects in supine position, 
the Task Force [1] calculated an average LFRRNU of 54, 
which is fairly similar to the average values in 4/5 of our 
subjects: 47 in CS, 45 in DC, and 39 in SS in supine po- 
sition during S3 + S4 at 122 m. Overall, the average 
LFRRNU reported by the Task Force [1] is somewhat 
lower than our data (54 vs 39 - 89, respectively). 
From a steady-state HRV analysis, Murrel and co- 
workers [24] found an average LFRRNU of 77 in the 
standing position and premarathon conditions, an average 
between 72 and 92 immediately after a marathon, and an 
average of 73 in the standing position at 48 h postmara- 
thon. These data appear similar to the data we recorded at 
122 m and 3480 m during the awakening, S1 + S2, S3 + 
S4, and REM stages of sleep. 
Specifically, at 122 m there was a decrease in LFRRNU 
as sleep depth increased; during the desynchronized phase 
of sleep (the awakening state), the LFRRNU reached the 
values observed during REM sleep. At 3480 m there was 
a decrease in LFRRNU as sleep deepened; during the de- 
synchronized phase of sleep (the awakening state) the 
LFRRNU reached the values recorded during the REM 
phases at 3480 m. 
5.8. High Frequency 
Efferent vagal activity is a major contributor to the high 
frequency (HF) component (Task Force, [1]) which pri- 
marily reflects respiration-driven vigil modulation of the 
sinus rhythm. Other factors such as voluntary controlled 
respiration, cold stimulation of the face or rotational mo- 
tor stimuli (see above) can occur physiologically during 
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sleeping and might confound results. Spectral analysis of 
stationary supine subjects revealed an average normal HF 
close to 975 ms2 (Task Force, [1]). Saito and co-workers 
[25] reported an average HF of 780  211 ms2 in 21 sub- 
jects during waking at low altitude and an average HF 
between 61  44 and 112  128 ms2 after exposure for 4 - 
6 h at PB 495 mm Hg. Lanfranchi and co-workers [2] 
reported an average HF between 102  37 and 157  43 
ms2 in subjects exposed to approximately 4500 m, or 
between 135  30 and 64  4 ms2 in those with no signs 
of AMS. Briefly, in the subjects without AMS there was 
a non significant increase in the HF component. At low 
altitude, the average HF in our five mountain marathon 
runners increased as sleep deepened and decreased dur- 
ing REM sleep to levels similar to those observed in the 
waking state. The average HF at altitude was 1572 ms2 
during the awakening state, 1610 ms2 during S1 + S2, 
1480 ms2 during S3 + S4, and 1159 ms2 during REM 
sleep. The average HF decreased during the sleep stages. 
Surprisingly, the average HF of 1159 ms2 during REM 
sleep at high altitude was lower than the average ob- 
served during the desynchronized state during waking. 
As reported by the Task Force [1], we also found the 
HF vigil component of the power spectrum to be aug- 
mented during NREM sleep at low altitude. 
5.9. HFRRNU 
The average of total power expressed in high frequency 
RR normalized units (HFRRNU) is considered a marker of 
vagal modulation of the autonomic system. The values 
that we found at low altitude during the awakening pe- 
riod (W) during sleep, during S2 + S3 and S3 + S4, and 
during REM sleep were similar to those Murrell and co- 
workers [24] recorded at premarathon, postmarathon, and 
48 h postmarathon assessment under controlled normal 
breathing and standing conditions. Our HFRRNU data 
recorded during the awakening period (W) during sleep 
at 122 and were similar to those they reported during 
REM sleep (23.47 versus 22.64, respectively). In their 
evaluation of LFRRNU, the average HF (controlled brea- 
thing) was 58.45 during the premarathon stage, 45 during, 
and 53 at 48 h postmarathon The average HFRRNU de- 
creased immediately after the race and at 48 h postmara- 
thon. All these values are very close to the average 
LFRRNU we recorded in the subjects during S3 + S4 
sleep at low altitude. 
Of note is that HFRRNU at low and at high altitudes 
increases at sleep onset and peaks during the deep stage 
of sleep (S3 + S4) at altitude (56.91). After exposure to 
3480 m at a PB of 495 mm Hg for 30 - 41 h there was a 
non significant reduction in HFRRNU across all sleep 
stages. The average HFRRNU during the awakening pe- 
riod (W) during sleep at 3480 m was lower but still simi- 
lar to that at 122 m. These values were similar, though 
lower, than those Murrell and co-workers [24] recorded 
immediately and at 48 h post-marathon at altitude. 
Our HFRRNU data recorded during sleep at 122 m and 
3480 m were also similar to those Lanfranchi and co- 
workers [2] reported in subjects without AMS and those 
with AMS (16 and 31, respectively) during the supposed 
diurnal state and after exposure to 4500 m. 
Compared with the HFRRNU reported by the Task 
Force [1], our data recorded during the awakening state, 
S1 + S2 and S3 + S4 and REM sleep at sea level and at 
3480 m were 21.31 and 31.11 respectively. 
5.10. LF:HF Ratio 
Exercise and training at low and high altitudes may have 
modified autonomic nervous system balance and thus the 
LF:HF ratio. The LF:HF ratio is considered by some in- 
vestigators as the mirror of sympathovagal balance or a 
reflection of sympathetic modulation (Ako et al. [3]). In 
agreement with Ako and co-workers [3], we observed, 
significantly at low altitude, but indeed also at high alti- 
tude, a significant decrease in the LF:HF component as 
sleep deepened. In agreement with Ako and co-workers 
[3], we also observed that the sympathetic nervous sys- 
tem is activated during the two desynchronisation phases 
of REM sleep and deactivated during NREM sleep at low 
and high altitude. 
In detail, we analyzed the dynamics of nocturnal fluc- 
tuations of autonomic nerve activities in sleep stages 
classified by Rechtschaffen and Kales’s criteria. These 
criteria have not yet been investigated in association with 
HRV indices, particularly during hypoxic conditions. 
Ako and co-workers [3] found an increase in the LF:HF 
ratio (2.51  0.17) during REM sleep and a significant 
linear decrease during NREM sleep (S1 2.30  0.29; S2 
1.85  0.09; S3 0.78  0.06; S4 2.51  0.17). Like Ako 
and co-workers [3], we noted a reduction in the LF:HF 
ratio at 122 m and at 3480 m during NREM sleep (S1 + 
S2122 m 3.1187; S1 + S23480 m 5.1242; S3 + S4122 m 1.6733; 
S3 + S43480 m 3.2109) and an increase during REM sleep 
(REM122 m 4.4739; REM3480 m 6.9132) to the level found 
during the awaking period (W) during sleep (W122m 
4.6446 and W3480 m 6.0036). We also found that the av- 
erage LF:HF ratio during S3 + S4 of NREM sleep at 122 
m (LF:HF = 1.6733) was similar to that reported by the 
Task Force [1] (LF:HF 1.5 - 2.0) in the spectral analysis 
of stationary supine 5-minute recordings. In our study, 
the average LF:HF ratio at 122 m and 3480 m during the 
awaking period (W) during sleep (W122 m 4.6446 and 
W3480 m 6.0036, respectively) was lower yet similar to the 
average LF:HF ratio Lanfranchi and co-workers [2] found 
during the waking state at 4500 m in mountaineers with 
and without AMS (3.4  1.3 and 8.3  14, respectively). 
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Saito and co-workers [25] found an average LF:HF ratio 
of 2.6  0.8 at PB 760 mm Hg at sea level during the re- 
laxed waking state. This was similar to the value we 
found (1.6733) during S3 + S4 at 122 m. They reported 
an average LF:HF ratio of 3.5  2.3 at 3456 m and at a PB 
of 495 mm Hg which was similar to the average of 
3.2109 that we recorded during S3 + S4 at 3480 m. The 
average LF:HF ratio that we found in all five mountain 
runners during S3 + S4 (1.6733  1.0847) at 122 m was 
similar to that reported by the Task Force [1]. In some of 
the mountain marathon runners, at low altitude, at 122 m, 
and after 30 - 41 h of acclimatization at 3480 m during 
the different stages of desynchronized and synchronized 
sleep, the average LF:HF ratio reached the normal values 
reported by the Task Force [1] (between 1.5 and 2.0). 
The LF:HF ratio value of 2, which is considered normal 
by the Task Force [1], was recorded at 122 m in: 1/5 sub- 
jects (SS) during the awakening period (W) of sleep; 3/5 
subjects (CS, DC, SS) during S1 + S2; and 5/5 subjects 
during S3 + S4; 2/5 subjects (CS, SS) during the REM 
sleep stage. A LF:HF ratio value of 2 was reached after 
30 - 41 h of acclimatization at 3480 m by: 1/5 subjects 
(GM) during the awakening period (W) of sleep; 1/5 
subjects (CS) during S1 + S2; and 2/5 subjects (CS, GM) 
during S3 + S4. No changes were noted between the av- 
erage LF:HF ratio recorded in all five mountain runners 
at 122 m and after 30 - 41 h of acclimatization at 3480 m 
and during all four stages of sleep: awakening period (W) 
during sleep; S1 + S2; S3 + S4; and REM sleep. These 
results suggest highly controlled regulation of sympa- 
thovagal balance on exposure to moderate hypoxia con- 
ditions. As reported in Table 7, several mountain mara- 
thon runners showed very high control of sympathovagal 
balance: their LF:HF ratio was similar to that reported by 
the Task Force [1] or did not differ between 122 m and 
3480 m, after 30 - 41 h of acclimatization, during the 
awakening period (W) during sleep, during S1 + S2; 
during S3 + S4, or during the REM sleep. Cornolo and 
co-workers [20] reported an average LF:HF ratio of ~6.0 
in trained high-altitude native subjects 6 - 8 h after the 
end of a marathon performed between 4100 and 4400 m. 
This was similar to the average LF:HF ratio that we re- 
corded at 3480 m during the desynchronized state of 
sleep, specifically, during the awakening period (W) dur- 
ing sleep (6.0036  5.0276) and during the REM sleep at 
the same altitude (6.9132  3.6806). 
5.11. Total Power 
We observed significant parallel changes in TP recorded 
at low (PB about 740 mm Hg) and high (PB 495 mm Hg) 
altitude between the awakening period (W) during sleep 
and S3 + S4 of sleep. We also found significant parallel 
changes in the TP recorded during REM sleep and the 
average of TP recorded during S3 + S4 at 122 and 3480 
m. These changes may reflect changes in cardiac, re- 
spiratory and sympathovagal balance. In general, in indi- 
vidual mountain marathon runners we found a decrease 
in the total power at altitude. The components of HRV 
are thought to be influenced by both neuronal and hu- 
moral factors (Task Force, [1]). Saito and co-workers [25] 
reported that humoral control of the autonomic nervous 
system plays an important role in the survival of victims 
under hypoxic conditions at high altitude. 
6. Functional Significance 
Physical training at low and high altitudes may have in- 
duced marked autonomic adaptations in the mountain 
marathon runners over the course of their years of train- 
ing. The resting heart rate was lower at sea level because 
parasympathetic modulation predominates over higher 
sympathetic control at high altitude. By constantly main- 
taining their training levels at low and high altitudes for 
more than 20 years, the mountain runners may have 
shifted their cardiovascular autonomic control toward a 
greater parasympathetic modulation, particularly at sea 
level. Rest and training under hypoxia conditions may 
have balanced the prevalence of parasympathetic modu- 
lation, as well as improved control of phasic sympathetic 
responses. 
These well-trained runners seem to be exceptionally 
adapted to the high altitude environment [4-13]. Strenu- 
ous exercise is known to induce profound cardiovascular 
modifications, but with a caveat for non-professional ma- 
rathoners.  
We agree with Lanfranchi et al., [2] that HRV analysis 
has proved to be essential for investigating the mountain 
sickness, the balance of the sympathetic and parasympa- 
thetic function of the autonomic nervous system at low 
and high altitude in mountain marathon runners. HRV 
analysis could also be very useful for evaluating de- 
creases in parasympathetic and increases in sympathetic 
tone of the autonomic nervous system during acclimati- 
zation at altitude of mountain marathon runners who ge- 
nerally have a tonic prevalence of parasympathetic tone 
at low altitude. 
R-R interval variability was observed in the mountain 
marathon runners during sleep at 122 m (i.e., a controlled 
increase in parasympathetic tone during NREM sleep and 
an increased sympathetic tone during the awakening pe- 
riod (W) during sleep and during REM sleep). At high 
altitude, the RR-intervals we observed were similar to 
those Sacknoff and co-workers [21] reported in athletes 
and controls. Moreover, the major ECG alterations evi- 
dent during sleep, at an altitude of 3480 m, at a PB of 495 
mm Hg, and after 30 - 41 hours of acclimatization, were 
an increase in HR, together with signs of sinus arrhyth- 
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mia during periodic breathing in S1 + S2 of NREM sleep 
and in REM sleep. 
This study did not find abnormal reductions in the R-R 
interval during the awakening period (W) during sleep, 
S1 + S2, S3 + S4 and REM sleep, between 30 and 41 h 
of acclimatization at 3480 m in these well-trained moun- 
tain marathon runners. 
The HRV data observed at altitude suggest that the 
runners possess an intrinsic high parasympathetic tone 
that at high altitude promptly compensates the physio- 
logical increase in sympathetic tone due to a periodic, 
significant decrease in peripheral oxygen saturation dur- 
ing sleep. 
Not in group average but in several individual runners 
we found a significant reduction in the LF component at 
high altitude which may be due to the rhythmic increase 
of sympathetic discharge of the central brain stem center.  
In comparison to the average calculated at low altitude, 
we also found a significant decrease in the average of the 
power of HF during S3 + S4 of NREM sleep at 3480 m. 
This significant reduction probably indicates a decrease 
in the vagal parasympathetic components of the brain- 
stem generator. 
The study demonstrates that cardiovascular modifi- 
cations during sleep and after 30 - 41 h of acclimatization 
at high altitude can occur even in mountain marathoners 
who have benefited from 20 years of training at low and 
high altitude. Physicians should therefore take the results 
of HRV analysis into account to improve the training and 
performance, particularly at altitude. 
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